{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":57,"total_is_capped":false,"direct_labels_cover":4,"predictions_cover":57,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"4ceb0606b211","filters":{"venue":"HIV Clinical Trials"}},"results":[{"id":"W1965948300","doi":"10.1310/hct1104-186","title":"Randomized, Comparative, Double-Blind, Double-Dummy, Multicenter Trial of Miconazole Buccal Tablet and Clotrimazole Troches for the Treatment of Oropharyngeal Candidiasis: Study of Miconazole Lauriad<sup>®</sup>Efficacy and Safety (SMiLES)","year":2010,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS oral health manifestations","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Tolerability; Miconazole; Clotrimazole; Buccal administration; Clinical trial; Randomized controlled trial; Adverse effect; Internal medicine; Pharmacology; Antifungal; Dermatology","authors":[{"name":"José Antonio Vázquez","is_ca":false},{"name":"Lauren L. Patton","is_ca":false},{"name":"Joel B. Epstein","is_ca":false},{"name":"Padaruth Ramlachan","is_ca":false},{"name":"Ismail Mitha","is_ca":false},{"name":"Zoja Noveljic","is_ca":false},{"name":"Jan Fourie","is_ca":false},{"name":"Brian Conway","is_ca":true},{"name":"Rajesh V. Lalla","is_ca":false},{"name":"Andrei Barasch","is_ca":false},{"name":"P Attali","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2931300087889962,"gpt":0.5013441931525906,"spread":0.2082141843635944,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003336526,0.002159079,0.003997672,0.0005343933,0.0005839388,0.001300316,0.001426129,0.002799978,0.006435498],"category_scores_gemma":[0.003667836,0.001105729,0.001855332,0.0005048841,0.002132224,0.001440718,0.0005019504,0.0032643,0.001244325],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007925323,"about_ca_system_score_gemma":0.001745363,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008333022,"about_ca_topic_score_gemma":0.001417218,"domain_scores_codex":[0.998413,0.0009575292,0.0001064079,0.0002503555,0.00009721208,0.0001754811],"domain_scores_gemma":[0.9971777,0.0009987383,0.0006965014,0.0002611241,0.0001918497,0.0006740845],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9876835,0.006018455,0.0002107522,0.0001934683,0.0002834375,0.00001436615,0.00002907261,0.0000934895,0.001321128,0.00004289693,0.0001971412,0.003912308],"study_design_scores_gemma":[0.9450132,0.05371943,0.0005510038,0.00001049944,0.0001308236,0.00001339566,0.000008947608,0.0001855846,0.0001971249,0.00003605858,0.0001276621,0.000006268732],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905521,0.002359209,0.0004991947,0.0004314122,0.0003966321,0.003927952,0.0005961951,0.0001127835,0.001124658],"genre_scores_gemma":[0.9863239,0.0015652,0.001875252,0.001015632,0.0005757314,0.00581271,0.0008945909,0.00003530563,0.001901638],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006435498,"threshold_uncertainty_score":0.02152884,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2411587754","doi":"10.1080/15284336.2016.1184827","title":"Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials","year":2016,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Maple Leaf Medical Clinic; University of Toronto; Public Health Ontario; University Health Network","funders":"Canadian Institutes of Health Research; Ontario HIV Treatment Network","keywords":"Medicine; Cart; Immune system; Inflammation; Systemic inflammation; Immunology; Tolerability; Probiotic; Population; Placebo; Gut flora; Internal medicine; Adverse effect; Biology; Pathology","authors":[{"name":"Connie J. Kim","is_ca":true},{"name":"Sharon Walmsley","is_ca":true},{"name":"Janet Raboud","is_ca":true},{"name":"Colin Kovacs","is_ca":true},{"name":"Bryan Coburn","is_ca":true},{"name":"Rodney Rousseau","is_ca":true},{"name":"Robert J. Reinhard","is_ca":true},{"name":"Ron Rosenes","is_ca":false},{"name":"Rupert Kaul","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1655538968730954,"gpt":0.4415779428807052,"spread":0.2760240460076098,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01269448,0.002245845,0.002999831,0.0005333059,0.0009553868,0.001465695,0.001299967,0.004297161,0.005772871],"category_scores_gemma":[0.01142367,0.001041998,0.003800991,0.0006447979,0.001532141,0.001804593,0.00102447,0.002757852,0.0007731933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006177974,"about_ca_system_score_gemma":0.001879301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008919303,"about_ca_topic_score_gemma":0.001660941,"domain_scores_codex":[0.9929307,0.00545342,0.0004753961,0.0003950501,0.0003201437,0.0004253467],"domain_scores_gemma":[0.9935901,0.002433987,0.001755193,0.0006191225,0.0005661162,0.001035359],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9662171,0.01528142,0.001134707,0.001110176,0.002335537,0.0000249805,0.00009652848,0.0002068219,0.001512583,0.0002048972,0.0003353397,0.01153989],"study_design_scores_gemma":[0.6251522,0.3678679,0.00236397,0.0001862444,0.002172176,0.00001608586,0.00005566357,0.0001789893,0.0005675448,0.000341005,0.001077545,0.00002059375],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9176172,0.01410518,0.003140828,0.002646879,0.00217266,0.05516075,0.001450824,0.00009182534,0.003613797],"genre_scores_gemma":[0.9018471,0.007013537,0.008406635,0.00365536,0.002088366,0.07236416,0.0009170729,0.00003020195,0.003677609],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.01269448,"threshold_uncertainty_score":0.06713563,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990715538","doi":"10.1310/hct0901-43","title":"Systematic Review and Meta–Analysis of the Diagnostic Accuracy of Fibrosis Marker Panels in Patients with HIV/Hepatitis C Coinfection","year":2008,"lang":"en","type":"review","venue":"HIV Clinical Trials","topic":"Hepatitis C virus research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Canadian Liver Foundation","keywords":"Medicine; Cirrhosis; Receiver operating characteristic; Fibrosis; Internal medicine; Coinfection; Hepatitis C; Liver biopsy; Hepatitis C virus; Gastroenterology; Meta-analysis; Odds ratio; Biopsy; Human immunodeficiency virus (HIV); Pathology; Immunology; Virus","authors":[{"name":"Abdel Aziz Shaheen","is_ca":true},{"name":"Robert P. Myers","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2869989979058875,"gpt":0.4954279116548407,"spread":0.2084289137489533,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.01739136,0.002661172,0.0174419,0.007559713,0.000717205,0.003307529,0.001974223,0.002308948,0.002786765],"category_scores_gemma":[0.05497394,0.00142139,0.03018155,0.007645672,0.000896352,0.001665078,0.001416459,0.001705791,0.0002521976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003204498,"about_ca_system_score_gemma":0.004470661,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008893125,"about_ca_topic_score_gemma":0.01739762,"domain_scores_codex":[0.9842152,0.008705362,0.004038578,0.00132255,0.001383558,0.0003347608],"domain_scores_gemma":[0.9586964,0.03277862,0.005256108,0.0009613477,0.002018285,0.0002892236],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001321992,0.00001823049,0.005385456,0.4011656,0.5787232,0.0001681119,0.00008290837,0.0006511523,0.0001929907,0.0001475362,0.000887166,0.01125552],"study_design_scores_gemma":[0.0003908304,0.0001435272,0.004552956,0.03580951,0.9567944,0.0001323817,0.00003330594,0.0002200139,0.0001135341,0.0002130856,0.001577164,0.00001931166],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004667839,0.9933978,0.000454449,0.0002476884,0.0001304185,0.0002545988,0.0006002552,0.00002117843,0.000225811],"genre_scores_gemma":[0.1968396,0.795909,0.003057427,0.001069118,0.0002913274,0.001298921,0.001207121,0.00003352204,0.0002939557],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9825581,"threshold_uncertainty_score":0.09197539,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987974009","doi":"10.1310/hct0804-213","title":"Safety, Tolerability, and Efficacy of Darunavir (TMC114) with Low-Dose Ritonavir in Treatment-Experienced, Hepatitis B or C Co-infected Patients in POWER 1 and 3","year":2007,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Darunavir; Ritonavir; Tolerability; Internal medicine; Regimen; Gastroenterology; Adverse effect; Hepatitis B; Hepatitis C; Alanine transaminase; Viral load; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy","authors":[{"name":"Anita Rachlis","is_ca":true},{"name":"Bonaventura Clotet","is_ca":false},{"name":"John D. Baxter","is_ca":false},{"name":"Robert L. Murphy","is_ca":false},{"name":"Éric Lefebvre","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09964593074584223,"gpt":0.4511300174849633,"spread":0.3514840867391211,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004762921,0.0006362012,0.001566964,0.000298823,0.0002386313,0.0008574667,0.0005009035,0.0006456831,0.00163006],"category_scores_gemma":[0.004932616,0.0003066702,0.002540127,0.0004079961,0.0006309228,0.0008004972,0.0004330406,0.00120212,0.0002408619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005135816,"about_ca_system_score_gemma":0.0006756937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002838796,"about_ca_topic_score_gemma":0.0006848008,"domain_scores_codex":[0.9974369,0.001892283,0.0002076879,0.0001709121,0.0001556749,0.0001365574],"domain_scores_gemma":[0.9974107,0.001056688,0.000901623,0.0001769817,0.0001421223,0.0003119702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7631201,0.003555113,0.0737532,0.001973254,0.007730757,0.0002908458,0.0004270825,0.001750196,0.01079281,0.0002020653,0.001617196,0.1347874],"study_design_scores_gemma":[0.4452388,0.3792976,0.1524857,0.000356112,0.008616622,0.001364468,0.0001894961,0.002055954,0.005253093,0.0005897721,0.004478663,0.00007368113],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909779,0.007418789,0.0002883256,0.0001965899,0.0000230614,0.0003089656,0.0001597268,0.00001693647,0.0006096733],"genre_scores_gemma":[0.9971789,0.001309264,0.0003581276,0.0002431931,0.00005353745,0.0003287069,0.000350395,0.000008016618,0.00017001],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004762921,"threshold_uncertainty_score":0.02518904,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050657418","doi":"10.1310/hct1101-39","title":"A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV Lipoatrophy","year":2010,"lang":"en","type":"review","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; University of Toronto","funders":"National Center for Research Resources; U.S. Public Health Service; National Institutes of Health; Amgen; National Institute of Diabetes and Digestive and Kidney Diseases; Gilead Sciences; National Institute of Allergy and Infectious Diseases; Medical Research Council; ACT Government; Bristol-Myers Squibb; GlaxoSmithKline; National Health and Medical Research Council","keywords":"Pioglitazone; Rosiglitazone; Medicine; Placebo; Thiazolidinedione; Stavudine; Internal medicine; Lipoatrophy; Body mass index; Zidovudine; Urology; Endocrinology; Gastroenterology; Pharmacology; Diabetes mellitus; Human immunodeficiency virus (HIV); Antiretroviral therapy; Type 2 diabetes; Viral load; Insulin; Immunology; Pathology","authors":[{"name":"Janet Raboud","is_ca":true},{"name":"Christina Diong","is_ca":true},{"name":"Andrew Carr","is_ca":false},{"name":"Steven Grinspoon","is_ca":false},{"name":"Kathleen Mulligan","is_ca":false},{"name":"Jussi Sutinen","is_ca":false},{"name":"William Rozenbaum","is_ca":false},{"name":"Rodrigo B. Cavalcanti","is_ca":true},{"name":"Handan Wand","is_ca":false},{"name":"Dominique Costagliola","is_ca":false},{"name":"Sharon Walmsley","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6418827890290362,"gpt":0.5873134464127776,"spread":0.05456934261625856,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01732977,0.003412073,0.0165198,0.004264886,0.0008336524,0.003805779,0.001803338,0.002493369,0.003678112],"category_scores_gemma":[0.0306158,0.001469375,0.04215649,0.004551911,0.0007534885,0.001301041,0.001158981,0.002474729,0.000279302],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001960634,"about_ca_system_score_gemma":0.001661818,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003996095,"about_ca_topic_score_gemma":0.007566742,"domain_scores_codex":[0.9815493,0.01200392,0.003008364,0.001933435,0.001127006,0.000378033],"domain_scores_gemma":[0.9821734,0.01334689,0.002719179,0.0007228736,0.0007431073,0.0002944605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01407377,0.00003751542,0.004629152,0.02667418,0.9480436,0.00009197537,0.00002227392,0.0007152434,0.0002705857,0.00005262334,0.0003054659,0.005083613],"study_design_scores_gemma":[0.002933981,0.0004004712,0.003629936,0.001379468,0.9906306,0.00005564919,0.00001582385,0.0002540208,0.00010365,0.0001055022,0.0004798258,0.00001119774],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04861517,0.9457967,0.001814665,0.0005147525,0.0005449856,0.0004818165,0.001479877,0.0001128127,0.0006391946],"genre_scores_gemma":[0.7598747,0.2304707,0.004219356,0.00138488,0.0004600842,0.001051115,0.00185673,0.00007801426,0.0006044435],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01732977,"threshold_uncertainty_score":0.09164965,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2048157797","doi":"10.1310/hct1202-89","title":"Ethnicity and Gender Differences in Lipodystrophy of HIV-Positive Individuals Taking Antiretroviral Therapy in Ontario, Canada","year":2011,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Kingston General Hospital; Sunnybrook Health Science Centre; St. Michael's Hospital; Women's College Hospital; Ontario HIV Treatment Network; Canadians Living with HIV; Health Sciences Centre; University Health Network; University of Toronto","funders":"Division of Undergraduate Education","keywords":"Lipodystrophy; Medicine; Lipoatrophy; Multicenter AIDS Cohort Study; Internal medicine; Cross-sectional study; Logistic regression; Ethnic group; Cohort; Prospective cohort study; Univariate analysis; Multivariate analysis; Antiretroviral therapy; Human immunodeficiency virus (HIV); Immunology; Pathology; Viral load","authors":[{"name":"Nisha Andany","is_ca":true},{"name":"Janet Raboud","is_ca":true},{"name":"Sharon Walmsley","is_ca":true},{"name":"Christina Diong","is_ca":true},{"name":"Sean B. Rourke","is_ca":true},{"name":"Sergio Rueda","is_ca":true},{"name":"Anita Rachlis","is_ca":true},{"name":"Wendy Wobeser","is_ca":true},{"name":"Rodger D. MacArthur","is_ca":false},{"name":"Louise Binder","is_ca":true},{"name":"Ron Rosenes","is_ca":true},{"name":"Mona Loutfy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3563934803590323,"gpt":0.4365928387934302,"spread":0.08019935843439796,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003531368,0.0001998667,0.0002933804,0.0008230872,0.002108975,0.0007514621,0.0004972862,0.0002637752,0.002150124],"category_scores_gemma":[0.001330765,0.0002131173,0.0003669409,0.00158437,0.0004828976,0.0002440869,0.0004627851,0.0002915134,0.0001517521],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006544298,"about_ca_system_score_gemma":0.006770886,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9593875,"about_ca_topic_score_gemma":0.9787171,"domain_scores_codex":[0.9995783,0.00003632748,0.00002698906,0.00005420646,0.0001497229,0.0001545812],"domain_scores_gemma":[0.999204,0.00005987164,0.0002623073,0.00002053602,0.0002469998,0.0002062673],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0000344026,0.000007873326,0.9976829,0.00000930753,0.00001503063,0.00006574212,0.0006563869,0.00001555987,0.0001170292,0.00002802179,0.0001990231,0.00116872],"study_design_scores_gemma":[0.000002220537,0.000007376304,0.9985953,0.0000153976,0.00000855764,0.00006567509,0.0009323077,0.00004780987,0.00001577258,0.00001065444,0.0002962207,0.00000271732],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996847,0.0005221662,0.00003960999,0.0001722561,0.000008567028,0.00001477797,0.000804608,0.000002300937,0.001588856],"genre_scores_gemma":[0.9988813,0.0002667643,0.00004692452,0.00005019989,0.000003225316,0.000006460295,0.0002943632,0.000001868287,0.0004488743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04061252,"threshold_uncertainty_score":0.08170331,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035341996","doi":"10.1310/hct1002-76","title":"Long-Term Efficacy and Safety of Fosamprenavir plus Ritonavir Versus Lopinavir/Ritonavir in Combination with Abacavir/Lamivudine over 144 Weeks","year":2009,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Clair College","funders":"GlaxoSmithKline","keywords":"Medicine; Abacavir; Lopinavir/ritonavir; Lopinavir; Ritonavir; Interquartile range; Lamivudine; Adverse effect; Viral load; Internal medicine; Gastroenterology; Pharmacology; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Virus; Chronic hepatitis","authors":[{"name":"Federico Pulido","is_ca":false},{"name":"Vicente Estrada","is_ca":false},{"name":"J.G. Baril","is_ca":false},{"name":"Ken Logue","is_ca":true},{"name":"Knud Schewe","is_ca":false},{"name":"Andreas Plettenberg","is_ca":false},{"name":"Dan Duiculescu","is_ca":false},{"name":"Linda H. Y. Yau","is_ca":false},{"name":"Cindy Vavro","is_ca":false},{"name":"Michael L. Lim","is_ca":false},{"name":"Cristina E. Pharo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.128906631394485,"gpt":0.4384300801451987,"spread":0.3095234487507136,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001712679,0.0007752854,0.001991201,0.0002701583,0.0002779223,0.0007666207,0.0006386851,0.0008773617,0.002968756],"category_scores_gemma":[0.00171849,0.0004868908,0.001323956,0.0002387891,0.0005922838,0.001092133,0.0003668376,0.001612578,0.0006004282],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006807208,"about_ca_system_score_gemma":0.0008173668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005274965,"about_ca_topic_score_gemma":0.001578606,"domain_scores_codex":[0.9990969,0.0005088157,0.00007516619,0.000136736,0.00008272997,0.00009967108],"domain_scores_gemma":[0.9984254,0.0003850808,0.0004835107,0.0001111131,0.0000993471,0.0004956244],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9465588,0.01139046,0.002684293,0.0004381113,0.000797844,0.0000660996,0.00009085446,0.0006789332,0.007249265,0.00004524251,0.0003698184,0.02963015],"study_design_scores_gemma":[0.4114017,0.5591303,0.02218602,0.00008049293,0.001028888,0.0001868383,0.00007045146,0.001165017,0.003371764,0.0001197577,0.001202208,0.0000565365],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964359,0.002292042,0.0001024667,0.00009232219,0.00004413862,0.0002234501,0.0002055596,0.00001629565,0.0005878952],"genre_scores_gemma":[0.9970933,0.0007019964,0.0003101122,0.0001400965,0.0000871107,0.0003168175,0.0003312092,0.000006066006,0.001013275],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002968756,"threshold_uncertainty_score":0.009931505,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985542358","doi":"10.1179/1528433614z.0000000005","title":"<i>Tripterygium wilfordii</i>Hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safety","year":2015,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Natural Compounds in Disease Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"University of California, San Francisco","keywords":"Medicine; Tripterygium wilfordii; Discontinuation; Tripterygium; Cart; Immune system; Triptolide; Internal medicine; Combination therapy; T cell; Pharmacology; Immunology; Apoptosis","authors":[{"name":"Taisheng Li","is_ca":false},{"name":"Jing Xie","is_ca":false},{"name":"Yijia Li","is_ca":false},{"name":"Jean‐Pierre Routy","is_ca":true},{"name":"Yanling Li","is_ca":false},{"name":"Yang Han","is_ca":false},{"name":"Zhifeng Qiu","is_ca":false},{"name":"Wei Lv","is_ca":false},{"name":"Xiaojing Song","is_ca":false},{"name":"Mengqing Sun","is_ca":false},{"name":"Xiaoying Zhang","is_ca":false},{"name":"Fu‐Sheng Wang","is_ca":false},{"name":"Hua Jiang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1926550705779997,"gpt":0.43823313118125,"spread":0.2455780606032503,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000431219,0.0003080572,0.0007025981,0.000178518,0.0002803462,0.0002594596,0.0002060141,0.0003724053,0.001723647],"category_scores_gemma":[0.0003991374,0.0001378138,0.0004662461,0.0001414811,0.0002208812,0.0002845657,0.0001733815,0.0004722072,0.000183664],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002224781,"about_ca_system_score_gemma":0.0003445082,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005120321,"about_ca_topic_score_gemma":0.0007909068,"domain_scores_codex":[0.9998711,0.00005258428,0.000009577642,0.00002004525,0.00001514177,0.00003154781],"domain_scores_gemma":[0.9997754,0.00005562517,0.00005567995,0.00001569103,0.00001928616,0.0000783885],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4086229,0.09543078,0.09099961,0.002574542,0.001728714,0.002323992,0.0009723681,0.0007423868,0.1219571,0.000170582,0.002122543,0.2723545],"study_design_scores_gemma":[0.04610148,0.8038392,0.137378,0.0001201511,0.0009345596,0.001108713,0.0003180819,0.0008173801,0.006290738,0.0000735259,0.002987445,0.00003068455],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985818,0.0008330668,0.00006683514,0.00003871458,0.00001181789,0.0002155361,0.00005448229,0.000005288434,0.0001926634],"genre_scores_gemma":[0.9984506,0.000594795,0.0002289158,0.0001435727,0.00004588176,0.0001625566,0.0001165693,0.000001857889,0.0002551603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001723647,"threshold_uncertainty_score":0.005766153,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2063088890","doi":"10.1310/hct1205-275","title":"Vitamin D Supplementation Does Not Increase Immunogenicity of Seasonal Influenza Vaccine in HIV-Infected Adults","year":2011,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"HIV Legal Network; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Immunogenicity; Medicine; Seroconversion; Influenza vaccine; Vitamin; Human immunodeficiency virus (HIV); Population; Virology; Immunology; Physiology; Internal medicine; Antibody; Environmental health; Vaccination","authors":[{"name":"Curtis Cooper","is_ca":true},{"name":"Anona Thorne","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1829241776040389,"gpt":0.4677940942539155,"spread":0.2848699166498766,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002465342,0.0002821519,0.001126046,0.0002327727,0.0002784018,0.000512676,0.0003890608,0.001243586,0.00175761],"category_scores_gemma":[0.005189147,0.0003611081,0.001170314,0.000217404,0.0004356553,0.0003938762,0.0002415074,0.0009774109,0.0001944492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002597968,"about_ca_system_score_gemma":0.0005087628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001284842,"about_ca_topic_score_gemma":0.002815956,"domain_scores_codex":[0.9985955,0.0009400382,0.0001460513,0.00009420219,0.0001352701,0.00008891657],"domain_scores_gemma":[0.9973696,0.001578582,0.000531992,0.0001570819,0.0001208704,0.0002418481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7909905,0.009568694,0.02571912,0.003730012,0.008627156,0.0001477717,0.0004104837,0.000535205,0.015265,0.0001893332,0.00133067,0.143486],"study_design_scores_gemma":[0.3427514,0.5075375,0.1253576,0.0008989044,0.009421765,0.0003095134,0.0002209738,0.0007614692,0.006754052,0.0005652518,0.005375966,0.00004558039],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876785,0.01024727,0.0001092958,0.000554763,0.0001526454,0.0001571806,0.000173221,0.00001347081,0.0009137354],"genre_scores_gemma":[0.9955814,0.003067605,0.0002554691,0.000458682,0.0001259714,0.0000697406,0.0001131535,0.000003796929,0.0003241608],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002465342,"threshold_uncertainty_score":0.0130381,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163692526","doi":"10.1310/vqxj-41x6-gja2-h6ag","title":"Effect of Protease Inhibitor-Based Highly Active Antiretroviral Therapy on Survival in HIV-Associated Advanced Kaposi's Sarcoma Patients Treated with Chemotherapy","year":2003,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Vincristine; Regimen; Sarcoma; Gastroenterology; Indinavir; Chemotherapy regimen; Anthracycline; Protease inhibitor (pharmacology); Surgery; Viral load; Human immunodeficiency virus (HIV); Antiretroviral therapy; Immunology; Cyclophosphamide; Pathology; Cancer","authors":[{"name":"Leitch Heather","is_ca":true},{"name":"Trudeau Marc","is_ca":false},{"name":"Routy Jean-Pierre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04470402048073586,"gpt":0.3771242272860323,"spread":0.3324202068052965,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005824482,0.0001253172,0.0003560133,0.0002260459,0.0002731156,0.000414867,0.0001233422,0.0003204809,0.0008861687],"category_scores_gemma":[0.00522603,0.00008261493,0.0003302402,0.0003777342,0.0002248074,0.000346799,0.0002219143,0.0004168983,0.00009825209],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001978051,"about_ca_system_score_gemma":0.0002099045,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000520961,"about_ca_topic_score_gemma":0.0009834301,"domain_scores_codex":[0.9995438,0.0002039479,0.00005327362,0.00004616378,0.00007162981,0.0000811734],"domain_scores_gemma":[0.9962115,0.001816333,0.001137775,0.00008828133,0.0002224737,0.0005236092],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.002495024,0.0001425349,0.980233,0.00003377368,0.0001613991,0.0003155145,0.0001267341,0.0003280672,0.0007215665,0.00002594068,0.0001684952,0.015248],"study_design_scores_gemma":[0.0001715049,0.003259904,0.993079,0.000039396,0.0001854254,0.001234112,0.0001851448,0.0008598168,0.000310111,0.00006203621,0.0006046323,0.000008837324],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984402,0.00101833,0.00003536391,0.00009584997,0.000008740511,0.000004938653,0.00006017124,0.000001795013,0.0003345894],"genre_scores_gemma":[0.9996424,0.0001566467,0.00003099785,0.00003887229,0.00002017551,0.00000336841,0.00006833754,4.969562e-7,0.00003868959],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008861687,"threshold_uncertainty_score":0.003080308,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2089422405","doi":"10.1310/0xh7-f2v2-1k0r-nu2w","title":"Prognostic Staging of Extensively Pretreated Patients with Advanced HIV-1 Disease","year":2005,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; University of British Columbia Hospital; St. Paul's Hospital","funders":"","keywords":"Medicine; Enfuvirtide; Regimen; Internal medicine; Confidence interval; Odds ratio; Viral load; Randomization; Logistic regression; Clinical trial; Human immunodeficiency virus (HIV); Immunology","authors":[{"name":"Julio Montaner","is_ca":true},{"name":"Denise Guimaraes","is_ca":false},{"name":"Jain Chung","is_ca":false},{"name":"Zarina Gafoor","is_ca":false},{"name":"Miklos Salgo","is_ca":false},{"name":"Ralph DeMasi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08973515316492171,"gpt":0.4063030425292003,"spread":0.3165678893642786,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000393825,0.0003254138,0.0002594384,0.0003261763,0.0002956957,0.0004884776,0.0002094493,0.0004105054,0.001769679],"category_scores_gemma":[0.002378024,0.0001089447,0.0001825547,0.0003191981,0.00033008,0.0003218904,0.0003325856,0.0004495455,0.0002524952],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001680402,"about_ca_system_score_gemma":0.0002427431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007077462,"about_ca_topic_score_gemma":0.001357737,"domain_scores_codex":[0.9998197,0.00006502965,0.00001846841,0.00002897048,0.00002125987,0.00004659127],"domain_scores_gemma":[0.9987803,0.0002999916,0.0005398149,0.00004174684,0.00005000933,0.0002881139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003854619,0.00001755929,0.9959216,0.000007859734,0.00001229156,0.00009166838,0.00002979785,0.0001007904,0.0002442318,0.00001931035,0.0001236007,0.003045875],"study_design_scores_gemma":[0.00003669859,0.0003242519,0.9964294,0.00002845429,0.00003901704,0.001231644,0.0001564428,0.001135603,0.0002159345,0.0001055636,0.000290721,0.000006353335],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987789,0.0004529945,0.00009062063,0.0000902379,0.000005147195,0.000007146548,0.00008713023,0.000003990994,0.0004838893],"genre_scores_gemma":[0.9995605,0.0000934862,0.00009199209,0.00001933597,0.00001628964,0.000004488917,0.0001560847,9.103105e-7,0.00005678402],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001769679,"threshold_uncertainty_score":0.005920231,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2078593189","doi":"10.1310/2xvk-pbgl-735n-wh72","title":"Concomitant Use of an Active Boosted Protease Inhibitor with Enfuvirtide in Treatment-Experienced, HIV-Infected Individuals: Recent Data and Consensus Recommendations","year":2006,"lang":"en","type":"review","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal General Hospital; Maple Leaf Medical Clinic","funders":"","keywords":"Enfuvirtide; Ritonavir; Concomitant; Medicine; Protease inhibitor (pharmacology); Lopinavir; Regimen; Viral load; Pharmacology; Internal medicine; Protease; Virology; Human immunodeficiency virus (HIV); Immunology; Gp41; Antiretroviral therapy; Biology; Enzyme","authors":[{"name":"Mike Youle","is_ca":false},{"name":"Schlomo Staszweski","is_ca":false},{"name":"Bonaventura Clotet","is_ca":false},{"name":"José Ramón Arribas","is_ca":false},{"name":"Anders Blaxhult","is_ca":false},{"name":"Giampiero Carosi","is_ca":false},{"name":"Edwin DeJesus","is_ca":false},{"name":"Gianni Di Perri","is_ca":false},{"name":"Vicente Estrada","is_ca":false},{"name":"Martin Fisher","is_ca":false},{"name":"Colin Kovacs","is_ca":true},{"name":"Ranjababu Kulasegaram","is_ca":false},{"name":"Adriano Lazzarin","is_ca":false},{"name":"Debbie Marriott","is_ca":false},{"name":"Leopoldo Muñoz","is_ca":false},{"name":"Jacques Reynes","is_ca":false},{"name":"Peter Shalit","is_ca":false},{"name":"Jihad Slim","is_ca":false},{"name":"Chris Tsoukas","is_ca":true},{"name":"A Vaccaro","is_ca":false},{"name":"José Vera","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4705395474442008,"gpt":0.5174414029777028,"spread":0.04690185553350196,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03511783,0.001413965,0.004544319,0.002713017,0.00166273,0.003794987,0.007160585,0.008396632,0.003004343],"category_scores_gemma":[0.03854967,0.001240701,0.005508603,0.002868865,0.001860185,0.003205138,0.002344244,0.00925835,0.002224484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002360878,"about_ca_system_score_gemma":0.009467993,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006483378,"about_ca_topic_score_gemma":0.01316475,"domain_scores_codex":[0.9778264,0.00723403,0.007568749,0.00126265,0.005282926,0.000825349],"domain_scores_gemma":[0.9306256,0.02425473,0.01072327,0.001391139,0.02939943,0.003605834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00116543,0.0006748271,0.005653528,0.04581587,0.002253017,0.0005411434,0.0006325732,0.00119692,0.001353269,0.003271429,0.1891602,0.7482818],"study_design_scores_gemma":[0.002872411,0.001231758,0.01995964,0.132063,0.007495023,0.001523996,0.001676841,0.002024881,0.001869771,0.01005452,0.8189473,0.0002808154],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004419148,0.7265776,0.01225092,0.2266198,0.01333676,0.001740347,0.001228974,0.0004101326,0.01341634],"genre_scores_gemma":[0.03574045,0.7249936,0.1009829,0.1107435,0.01229682,0.004054296,0.004403945,0.0001936213,0.006590705],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03511783,"threshold_uncertainty_score":0.1857231,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2058157173","doi":"10.1310/a9b9-rqd7-u8ka-503u","title":"Comparison of Prognostic Importance of Latest CD4+ Cell Count and HIV RNA Levels in Patients with Advanced HIV Infection on Highly Active Antiretroviral Therapy","year":2005,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Viral load; Medicine; Hazard ratio; Regimen; Antiretroviral therapy; Internal medicine; Immunology; Human immunodeficiency virus (HIV); Virology; Gastroenterology; Confidence interval","authors":[{"name":"Rodger D. MacArthur","is_ca":false},{"name":"George Perez","is_ca":false},{"name":"Sharon Walmsley","is_ca":true},{"name":"John D. Baxter","is_ca":false},{"name":"Christopher M. Mullin","is_ca":false},{"name":"James D. Neaton","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1052719748358848,"gpt":0.4184110854366108,"spread":0.313139110600726,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009412926,0.0003274888,0.0005306415,0.0004530898,0.0003098185,0.0006290765,0.0003285567,0.0006224568,0.001164851],"category_scores_gemma":[0.004360761,0.0001696485,0.0003951222,0.0006833522,0.0003533475,0.0004717759,0.0003238968,0.0005870381,0.0001377155],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001741261,"about_ca_system_score_gemma":0.0001937644,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000871746,"about_ca_topic_score_gemma":0.0008638123,"domain_scores_codex":[0.9995075,0.0002150535,0.00004180083,0.00007494965,0.00008678588,0.00007391289],"domain_scores_gemma":[0.9955705,0.002336892,0.00114268,0.000128489,0.00016674,0.0006547525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009322595,0.00002683169,0.9969433,0.00001046298,0.0000661573,0.00005705341,0.0000228053,0.0001039683,0.00010178,0.000007760288,0.00004897754,0.001678674],"study_design_scores_gemma":[0.00005546216,0.0004422092,0.9980668,0.000008117261,0.00006393551,0.0004298643,0.00007886763,0.0006254095,0.00007210446,0.00004463732,0.0001059648,0.000006515154],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.999202,0.0004895274,0.00003846847,0.00004567177,0.000004885729,0.000002497441,0.0000814129,0.000001449329,0.0001342054],"genre_scores_gemma":[0.9996525,0.00009490087,0.00003661571,0.0000158133,0.00002179386,0.000001773942,0.0001456083,6.789507e-7,0.00003022752],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001164851,"threshold_uncertainty_score":0.004978061,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1991408322","doi":"10.1310/hct0806-400","title":"Effectiveness and Tolerability of Oral Administration of Low-Dose Salmon Oil to HIV Patients with HAART-Associated Dyslipidemia","year":2007,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Abbott (Canada); Université Laval; Centre hospitalier de l'Université Laval; Maple Leaf Medical Clinic","funders":"Abbott Canada; Abbott Laboratories","keywords":"Medicine; Dyslipidemia; Tolerability; Fish oil; Adverse effect; Concomitant; Internal medicine; Triglyceride; Gastroenterology; Cholesterol; Fish <Actinopterygii>; Fishery; Disease","authors":[{"name":"Jean-Guy Baril","is_ca":false},{"name":"Colin Kovacs","is_ca":true},{"name":"Sylvie Trottier","is_ca":true},{"name":"Ghislaine O. Roederer","is_ca":false},{"name":"Alain Martel","is_ca":true},{"name":"N Ackad","is_ca":true},{"name":"Theodoro Koulis","is_ca":false},{"name":"John S. Sampalis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09556612374720039,"gpt":0.4636352470363737,"spread":0.3680691232891733,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009136818,0.0004623576,0.001332883,0.0001931093,0.000222985,0.00044419,0.0003323197,0.0006369924,0.001684322],"category_scores_gemma":[0.001877737,0.0002361858,0.0006658613,0.0001718922,0.0004750308,0.0004822925,0.0001934478,0.0009970935,0.0001598721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003876289,"about_ca_system_score_gemma":0.0005089986,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000397652,"about_ca_topic_score_gemma":0.000942766,"domain_scores_codex":[0.9995195,0.0003002082,0.00004747392,0.0000497162,0.00004326229,0.00003996215],"domain_scores_gemma":[0.9989135,0.0003325862,0.0003940803,0.00005376444,0.0000527826,0.0002533676],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8184071,0.01806327,0.01855319,0.000925101,0.001349579,0.0001416518,0.0001309072,0.0006081492,0.01846971,0.00006228428,0.0004302745,0.1228588],"study_design_scores_gemma":[0.2411002,0.6940553,0.05581754,0.0001493154,0.001253613,0.0002729703,0.0001414072,0.001544084,0.00458817,0.00009403721,0.0009459957,0.00003741737],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973863,0.002057161,0.00009707276,0.00008906751,0.00002752762,0.00009720802,0.00004922797,0.00001083441,0.0001855749],"genre_scores_gemma":[0.9985051,0.0006901284,0.0003380517,0.0001113196,0.0000601428,0.00008545937,0.00008283314,0.000002444906,0.0001244927],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001684322,"threshold_uncertainty_score":0.005634546,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085481779","doi":"10.1310/hct1105-260","title":"A Pilot Study of Abacavir/Lamivudine and Raltegravir in Antiretroviral-Naïve HIV-1–Infected Patients: 48-Week Results of the SHIELD Trial","year":2010,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"University of Saskatchewan","keywords":"Raltegravir; Abacavir; Medicine; Lamivudine; Adverse effect; Viral load; Internal medicine; Discontinuation; Gastroenterology; Human immunodeficiency virus (HIV); Virology; Chronic hepatitis; Antiretroviral therapy","authors":[{"name":"Benjamin Young","is_ca":false},{"name":"Thanes Vanig","is_ca":false},{"name":"Edwin DeJesus","is_ca":false},{"name":"Trevor Hawkins","is_ca":false},{"name":"Marty St. Clair","is_ca":false},{"name":"Linda Yau","is_ca":false},{"name":"Belinda Ha","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.152403599521089,"gpt":0.4151683571378847,"spread":0.2627647576167957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002806151,0.001262765,0.001984728,0.0002237306,0.0002693836,0.0006817481,0.0006314312,0.0008410513,0.003658925],"category_scores_gemma":[0.00184219,0.0005161611,0.001917338,0.0001936091,0.0008520141,0.0008057312,0.0003984352,0.002064219,0.0007178844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003796002,"about_ca_system_score_gemma":0.0009486253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006258042,"about_ca_topic_score_gemma":0.001044511,"domain_scores_codex":[0.9990056,0.0006769256,0.00005140017,0.00007819194,0.0000596328,0.0001282211],"domain_scores_gemma":[0.9977953,0.0005868124,0.0003753918,0.0002213954,0.0001399112,0.0008811938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9373628,0.01645251,0.007231602,0.0002617518,0.001377932,0.0002011923,0.0002115625,0.0007251567,0.009383985,0.0001129024,0.001425096,0.02525352],"study_design_scores_gemma":[0.5367233,0.4444253,0.01439355,0.00002827197,0.0006339425,0.0002963133,0.00007108827,0.0007540789,0.001329568,0.0001083542,0.001206389,0.00002987548],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973501,0.0008515724,0.0001632757,0.000213658,0.00005578041,0.0003534896,0.0003530605,0.00004222513,0.0006168308],"genre_scores_gemma":[0.9958704,0.0005273632,0.0007633734,0.0003519279,0.0002137071,0.0004594284,0.000894565,0.00001676535,0.0009024845],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003658925,"threshold_uncertainty_score":0.01484054,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2023680960","doi":"10.1310/hct1106-340","title":"Effect of Gender and Calendar Year on Time to and Duration of Virologic Suppression Among Antiretroviral-Naïve HIV-Infected Individuals Initiating Combination Antiretroviral Therapy","year":2010,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Women's College Hospital; Maple Leaf Medical Clinic; Ontario HIV Treatment Network; St. Michael's Hospital; Public Health Ontario; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Health Canada; Ontario HIV Treatment Network","keywords":"Medicine; Cart; Interquartile range; Hazard ratio; Regimen; Proportional hazards model; Viral load; Antiretroviral therapy; Cohort; Internal medicine; Human immunodeficiency virus (HIV); Cohort study; Confidence interval; Immunology","authors":[{"name":"Janet Raboud","is_ca":true},{"name":"Sandra Blitz","is_ca":true},{"name":"Sharon Walmsley","is_ca":true},{"name":"Courtney Thompson","is_ca":true},{"name":"Sean B. Rourke","is_ca":true},{"name":"Mona Loutfy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09042930505775788,"gpt":0.447746397133398,"spread":0.3573170920756401,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001037181,0.0002554293,0.0002629609,0.0004179169,0.0003580516,0.0004705754,0.0003527753,0.0002724966,0.002078389],"category_scores_gemma":[0.004536566,0.0001841705,0.0006790759,0.0004937368,0.000206791,0.0002744918,0.0002960404,0.0003584612,0.0001661576],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006410806,"about_ca_system_score_gemma":0.001112459,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04978685,"about_ca_topic_score_gemma":0.08130975,"domain_scores_codex":[0.9994861,0.0001416403,0.00002787967,0.00008429745,0.000115823,0.0001442529],"domain_scores_gemma":[0.9974858,0.0005604784,0.001101258,0.0001526366,0.000220401,0.0004794643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006258752,0.00001789774,0.9967014,0.000009452632,0.00007602952,0.00003741724,0.00004683345,0.00004712656,0.0001041534,0.0000114544,0.0001988069,0.002123638],"study_design_scores_gemma":[0.000009092059,0.00009372459,0.999274,0.000009649434,0.00004185647,0.00006557623,0.00004606777,0.0001687709,0.00003184655,0.00001105823,0.0002457035,0.000002631096],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950681,0.002165537,0.0001191364,0.0002484653,0.00004469162,0.000009843884,0.001326165,0.000008715818,0.001009365],"genre_scores_gemma":[0.9987582,0.0003882752,0.00005777562,0.00004624572,0.00001549277,0.000004032244,0.0003813115,0.000003474262,0.0003452065],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04978685,"threshold_uncertainty_score":0.09899414,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071621051","doi":"10.1310/hag3-8ya5-udqc-36nx","title":"Virologic and Immunologic Response to a Boosted Double-Protease Inhibitor-Based Therapy in Highly Pretreated HIV-1-Infected Patients","year":2005,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal Victoria Hospital; Royal Victoria Regional Health Centre; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Abbott Canada; Abbott Laboratories","keywords":"Saquinavir; Medicine; Lopinavir; Regimen; Protease inhibitor (pharmacology); Internal medicine; Ritonavir; Viral load; Lamivudine; Gastroenterology; Immunology; Odds ratio; Reverse-transcriptase inhibitor; Nelfinavir; Drug resistance; Pharmacology; Virology; Virus; Antiretroviral therapy; Biology","authors":[{"name":"Graham Smith","is_ca":true},{"name":"Mohamed‐Rachid Boulassel","is_ca":true},{"name":"Marina Klien","is_ca":false},{"name":"Nobert Gilmore","is_ca":false},{"name":"J MacLeod","is_ca":false},{"name":"Roger LeBlanc","is_ca":false},{"name":"Pierre René","is_ca":false},{"name":"Jean‐Pierre Routy","is_ca":true},{"name":"Richard Lalonde","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1259546533319276,"gpt":0.4069000041686832,"spread":0.2809453508367556,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004548088,0.0002461418,0.0003660928,0.00009900496,0.0001725638,0.0002564621,0.0001162406,0.0002803366,0.0008579175],"category_scores_gemma":[0.001198635,0.0001410952,0.0002033455,0.00008552198,0.000213961,0.0001641363,0.0001327234,0.0004154649,0.0001061603],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001691989,"about_ca_system_score_gemma":0.0001846611,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001984452,"about_ca_topic_score_gemma":0.0003487766,"domain_scores_codex":[0.9997728,0.0001104572,0.00002285605,0.00003366112,0.00002974998,0.00003036204],"domain_scores_gemma":[0.9992679,0.0002199881,0.000241047,0.00003383141,0.00003305326,0.0002041519],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.02974271,0.002016963,0.8784977,0.0002081305,0.0003032075,0.0008879478,0.0002511908,0.001009922,0.03751842,0.00006491165,0.0004399942,0.04905885],"study_design_scores_gemma":[0.001923323,0.04447665,0.943252,0.00003217189,0.0001434657,0.002679296,0.0001144974,0.001569511,0.005001983,0.00004648446,0.0007418416,0.00001884925],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995541,0.0002386435,0.00004673899,0.00001782913,0.000003032066,0.00001110122,0.00001849888,0.000002656605,0.0001075293],"genre_scores_gemma":[0.9995849,0.00005921665,0.000157174,0.00004823899,0.00001507975,0.000009350279,0.00006714677,7.502152e-7,0.00005798121],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008579175,"threshold_uncertainty_score":0.002870023,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988473048","doi":"10.1310/feed-6t8u-0bug-6hqh","title":"Randomized Trials Stopped Early for Harm in HIV/AIDS: A Systematic Survey","year":2006,"lang":"en","type":"review","venue":"HIV Clinical Trials","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; University of British Columbia; AIDS Vancouver; University of Ottawa","funders":"International AIDS Society","keywords":"Medicine; Data monitoring committee; Interim; Harm; Randomized controlled trial; Adverse effect; Psychological intervention; Clinical trial; Population; Family medicine; Environmental health; Internal medicine; Psychiatry","authors":[{"name":"Edward Mills","is_ca":false},{"name":"Curtis Cooper","is_ca":true},{"name":"Ping Wu","is_ca":false},{"name":"Beth Rachlis","is_ca":true},{"name":"Sonal Singh","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.9477098910306675,"gpt":0.7483044210610479,"spread":0.1994054699696196,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3155687,0.001582632,0.01042296,0.0161679,0.001433602,0.007089071,0.00289424,0.004228772,0.003507118],"category_scores_gemma":[0.6302441,0.0022309,0.01151257,0.0198856,0.003319046,0.01141554,0.004016913,0.003912388,0.0006440047],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006116856,"about_ca_system_score_gemma":0.01421453,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002123697,"about_ca_topic_score_gemma":0.004046915,"domain_scores_codex":[0.4714048,0.2259313,0.2489815,0.01229751,0.03942938,0.001955597],"domain_scores_gemma":[0.153461,0.6091048,0.1816826,0.01596686,0.03693375,0.002851164],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.004511744,0.0001870239,0.05507306,0.7426156,0.04008109,0.0002189022,0.00282602,0.000547873,0.0004046139,0.003017606,0.008205337,0.1423111],"study_design_scores_gemma":[0.004239805,0.001488202,0.05583158,0.8469326,0.04895367,0.0008612068,0.002165788,0.001000009,0.0008269304,0.005423483,0.03205656,0.0002200942],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04277086,0.9126918,0.009519934,0.007158005,0.0008667507,0.01724971,0.00728974,0.0002236763,0.002229554],"genre_scores_gemma":[0.3821701,0.4836297,0.04868992,0.01559152,0.0009051153,0.06048175,0.007302799,0.0002668425,0.000962267],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9895771,"threshold_uncertainty_score":0.8440257,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003655730","doi":"10.1310/b6t0-n98j-1j3m-eqpk","title":"Case series assessing the safety of mycophenolate as part of multidrug rescue treatment regimens","year":2002,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AIDS Vancouver; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Adverse effect; Abacavir; Mycophenolate; Internal medicine; Salvage therapy; Human immunodeficiency virus (HIV); Pharmacology; Viral load; Immunology; Antiretroviral therapy; Chemotherapy; Transplantation","authors":[{"name":"Natasha Press","is_ca":true},{"name":"Gil Kimel","is_ca":true},{"name":"Marianne Harris","is_ca":true},{"name":"Benita Yip","is_ca":true},{"name":"Kevin J.P. Craib","is_ca":true},{"name":"Julio Montaner","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2900278795689513,"gpt":0.4613258626269102,"spread":0.1712979830579589,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008011058,0.001459228,0.001015548,0.001368696,0.002492025,0.001719351,0.001091129,0.004602058,0.00431301],"category_scores_gemma":[0.01008442,0.0008726664,0.001173193,0.001068482,0.00148842,0.001321067,0.0009014373,0.002928995,0.001466829],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001307181,"about_ca_system_score_gemma":0.001209966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001610271,"about_ca_topic_score_gemma":0.001504417,"domain_scores_codex":[0.9985837,0.0004030925,0.0001693478,0.0002070532,0.000236391,0.0004003322],"domain_scores_gemma":[0.9941367,0.002717432,0.001197355,0.0005746346,0.0002739146,0.001100005],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"observational","study_design_scores_codex":[0.0003546937,0.0004333137,0.04375153,0.00005857556,0.00004743991,0.9484406,0.0003900777,0.0001641081,0.0004976689,0.0001853998,0.0008116782,0.004864954],"study_design_scores_gemma":[0.0001000652,0.0005686479,0.007541405,0.00002018632,0.00002808249,0.9897385,0.00016582,0.0002432079,0.0004321754,0.00007743913,0.001071923,0.00001253056],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9844998,0.002735318,0.001044868,0.001251548,0.000217921,0.0001400814,0.0001171841,0.00006399672,0.009929302],"genre_scores_gemma":[0.9966685,0.0008457408,0.0004199726,0.0005938035,0.0003760644,0.00004196792,0.0001093785,0.00001893978,0.0009257155],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004602058,"threshold_uncertainty_score":0.0144285,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2144136328","doi":"10.1310/hct1105-312","title":"A Randomized, Placebo-Controlled Trial of Abacavir Intensification in HIV-1–Infected Adults With Virologic Suppression on a Protease Inhibitor–Containing Regimen","year":2010,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; College of Medicine, University of Cincinnati; University at Buffalo; University of California, San Diego; BioCryst; Deutsches Krebsforschungszentrum; International AIDS Society; University of Cincinnati; Johns Hopkins University; ACT Government; Georgia Clinical and Translational Science Alliance; Tulane University; University of Minnesota; University of Rochester; University of Miami; Northwestern University; York University; Bristol-Myers Squibb; University of Pennsylvania; Gilead Sciences; Vanderbilt University; Emory University; University of Nebraska Medical Center; National Institutes of Health; Ohio State University; University of Southern California; GlaxoSmithKline","keywords":"Medicine; Abacavir; Zidovudine; Regimen; Internal medicine; Lamivudine; Clinical endpoint; Placebo; Viral load; Indinavir; Population; Efavirenz; Discontinuation; Adverse effect; Gastroenterology; Randomized controlled trial; Immunology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Viral disease; Virus; Pathology","authors":[{"name":"Scott M. Hammer","is_ca":false},{"name":"Heather J. Ribaudo","is_ca":false},{"name":"Roland Bassett","is_ca":false},{"name":"John W. Mellors","is_ca":false},{"name":"Lisa M. Demeter","is_ca":false},{"name":"Robert W. Coombs","is_ca":false},{"name":"Judith S. Currier","is_ca":false},{"name":"Gene D. Morse","is_ca":false},{"name":"John G. Gerber","is_ca":false},{"name":"Ana I. Martínez","is_ca":false},{"name":"William Spreen","is_ca":false},{"name":"Margaret A. Fischl","is_ca":false},{"name":"Kathleen Squires","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06691439298854879,"gpt":0.3846769090118663,"spread":0.3177625160233175,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002076561,0.001884017,0.004260548,0.0005837897,0.0007275556,0.001419706,0.001184083,0.002688282,0.01022291],"category_scores_gemma":[0.00295745,0.0009489688,0.001898804,0.0004269795,0.001678214,0.00122319,0.0005478815,0.003866172,0.001260684],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007457724,"about_ca_system_score_gemma":0.001363518,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001220454,"about_ca_topic_score_gemma":0.002121684,"domain_scores_codex":[0.9986517,0.0007838696,0.000096193,0.0002290623,0.00008645023,0.0001527913],"domain_scores_gemma":[0.9982439,0.0005811612,0.0003719084,0.0001590067,0.0001357602,0.0005082178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.99116,0.004087322,0.0001377334,0.0002661976,0.0003261497,0.00001508062,0.00002137925,0.00005870277,0.0005574388,0.00004323257,0.0001783007,0.00314847],"study_design_scores_gemma":[0.9819748,0.01726305,0.0003353001,0.00001437234,0.0001141901,0.000007034631,0.00000632212,0.00009277547,0.00005538672,0.00003477219,0.00009842792,0.000003632164],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9800878,0.004315723,0.0005665979,0.0008718938,0.001771668,0.008651124,0.0008272219,0.0001449707,0.002762921],"genre_scores_gemma":[0.9833013,0.002184738,0.001843782,0.001329457,0.001062064,0.007126288,0.0007150077,0.00001902317,0.002418377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01022291,"threshold_uncertainty_score":0.03419906,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1970660282","doi":"10.1310/9m23-qn0x-w6n8-80jd","title":"Long-Term Follow-up of a Cohort of HIV-Infected Patients Who Discontinued Maintenance Therapy for Cytomegalovirus Retinitis","year":2006,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Lunenfeld-Tanenbaum Research Institute; Sunnybrook Hospital; University of Toronto; University Health Network","funders":"Ontario HIV Treatment Network","keywords":"Cytomegalovirus retinitis; Medicine; Discontinuation; Retinitis; Maintenance therapy; Cohort; Internal medicine; Cytomegalovirus; Prospective cohort study; Immunology; Human cytomegalovirus; Viral disease; Human immunodeficiency virus (HIV); Herpesviridae; Chemotherapy; Virus","authors":[{"name":"Sharon Walmsley","is_ca":true},{"name":"Janet Raboud","is_ca":true},{"name":"Jonathan B. Angel","is_ca":true},{"name":"Tony Mazzulli","is_ca":true},{"name":"Sandy Shen","is_ca":true},{"name":"Lidia Casciaro","is_ca":true},{"name":"Charlene D. Young","is_ca":true},{"name":"George Moussa","is_ca":true},{"name":"Kevin Gough","is_ca":true},{"name":"Anita Rachlis","is_ca":true},{"name":"J. Jill Hopkins","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1184162698467506,"gpt":0.4288857596610925,"spread":0.310469489814342,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006860276,0.0003500114,0.0005578267,0.0006193904,0.0009561341,0.0009508568,0.0003064002,0.0005617194,0.001024701],"category_scores_gemma":[0.002743259,0.0003098906,0.0005486118,0.0004628265,0.0002835701,0.0007449385,0.0003733554,0.001069876,0.0003029699],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003113639,"about_ca_system_score_gemma":0.0003520838,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003203907,"about_ca_topic_score_gemma":0.001911948,"domain_scores_codex":[0.9996238,0.00007709567,0.00002847178,0.00009086014,0.00007000728,0.0001097835],"domain_scores_gemma":[0.9983568,0.0002880172,0.0005587453,0.0001566408,0.0002132565,0.0004265775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002405833,0.00009923587,0.9974921,0.000003726848,0.00004191561,0.0002603144,0.00008211477,0.00003085009,0.0003495563,0.000007388447,0.00006092477,0.001331388],"study_design_scores_gemma":[0.0000392584,0.0008953232,0.9965476,0.00001242272,0.00007935166,0.001389543,0.0002342779,0.0003119619,0.0001599844,0.00002553127,0.0002952844,0.000009473039],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995858,0.0001168535,0.00004684838,0.00002470898,0.000005583163,0.000006302416,0.00009936681,0.000001573398,0.0001129426],"genre_scores_gemma":[0.9994292,0.00006443254,0.00004687822,0.00003461112,0.00001295091,0.000009431074,0.0002738397,0.000001394716,0.000127232],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003203907,"threshold_uncertainty_score":0.006370485,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034769242","doi":"10.1310/3hhb-59up-93mm-aaxy","title":"HIV Lipodystrophy: A Review","year":2000,"lang":"en","type":"review","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Lipodystrophy; Medicine; Stavudine; Diabetes mellitus; Hyperlipidemia; Metabolic syndrome; Antiretroviral therapy; Bioinformatics; Human immunodeficiency virus (HIV); Intensive care medicine; Immunology; Endocrinology; Viral load; Biology","authors":[{"name":"Stephen Kravcik","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5069420519687867,"gpt":0.6030165185156607,"spread":0.09607446654687402,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000500941,0.001089867,0.002160354,0.003751758,0.0003489675,0.001187886,0.0009843525,0.0009372722,0.007101113],"category_scores_gemma":[0.0007362955,0.0003508088,0.0004880069,0.005325715,0.0003068059,0.001481722,0.0005634067,0.0009791063,0.003061747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005920239,"about_ca_system_score_gemma":0.001441933,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001569278,"about_ca_topic_score_gemma":0.003190647,"domain_scores_codex":[0.9997887,0.00004174923,0.00004665643,0.00002886539,0.00007980174,0.00001420293],"domain_scores_gemma":[0.9996558,0.000165078,0.00006675394,0.000007820639,0.00007379185,0.00003074032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009880665,0.0001303666,0.0001955625,0.04641248,0.0001437809,0.0004911287,0.00008759846,0.0002729891,0.0007541917,0.001081559,0.04349226,0.9068393],"study_design_scores_gemma":[0.00005208918,0.0001475078,0.00155764,0.01828609,0.0003371021,0.002867673,0.0001491244,0.00007870416,0.000212451,0.001142196,0.9751478,0.00002159972],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008163592,0.998888,0.00004494776,0.0001117317,0.0001641281,0.000009552898,0.00001711105,0.000004777371,0.0006782064],"genre_scores_gemma":[0.0002824229,0.998983,0.0001546756,0.0001045514,0.0001214505,0.000009929252,0.00002180792,6.287534e-7,0.0003215717],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007101113,"threshold_uncertainty_score":0.02375561,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988113084","doi":"10.1310/f45l-fdkk-y48n-n2bt","title":"Comparative CD4 T-Cell Responses of Reverse Transcriptase Inhibitor Therapy With or Without Nelfinavir Matched for Viral Exposure","year":2001,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Nelfinavir; Medicine; Viral load; Quartile; Protease inhibitor (pharmacology); Internal medicine; Amprenavir; Indinavir; Area under the curve; Gastroenterology; Immunology; Pharmacology; Confidence interval; Virus; Protease; Antiretroviral therapy","authors":[{"name":"Stephen Kravcik","is_ca":true},{"name":"A Magill","is_ca":false},{"name":"Bharati Sanghvi","is_ca":false},{"name":"Richard C. Ogden","is_ca":false},{"name":"D. William Cameron","is_ca":true},{"name":"Ron Lewis","is_ca":false},{"name":"George Yü","is_ca":false},{"name":"Andrew D. Badley","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.336951842305224,"gpt":0.4781353444316747,"spread":0.1411835021264507,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002325882,0.0003723467,0.001200382,0.0003204195,0.0001894408,0.0006334043,0.0003025211,0.0006712785,0.001410936],"category_scores_gemma":[0.003699375,0.0002665229,0.0008821709,0.000337997,0.0004338717,0.0006038616,0.000275743,0.001009068,0.0002229231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003064344,"about_ca_system_score_gemma":0.0003224122,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001242197,"about_ca_topic_score_gemma":0.0001600694,"domain_scores_codex":[0.997942,0.001028887,0.0002476388,0.0002945206,0.000218273,0.0002685577],"domain_scores_gemma":[0.9971413,0.001421712,0.0005612683,0.0002900193,0.000183599,0.0004019956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8507496,0.009051963,0.03829796,0.0004371828,0.002618148,0.0001800892,0.0001914059,0.001947881,0.0423766,0.0001837985,0.0005003122,0.05346509],"study_design_scores_gemma":[0.08001123,0.7420616,0.1496257,0.00006241125,0.002578276,0.0004510477,0.0001064206,0.002165246,0.02062209,0.0003836198,0.00189119,0.00004111786],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981488,0.001014304,0.0001612397,0.00002575406,0.00002223164,0.00008316874,0.0001401095,0.000005747702,0.0003986678],"genre_scores_gemma":[0.9986445,0.0001932184,0.0002258553,0.00006963648,0.00005492887,0.0001845383,0.0004677747,0.000002524481,0.0001571035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002325882,"threshold_uncertainty_score":0.01230055,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2013976388","doi":"10.1310/p52n-kxjh-1945-ux7x","title":"The Cost-Effectiveness of Triple Nucleoside Analogue Therapy Antiretroviral Regimens in the Treatment of HIV in the United Kingdom","year":2000,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Life expectancy; Nucleoside analogue; Quality-adjusted life year; Cost effectiveness; Clinical trial; Quality of life (healthcare); Observational study; Population; Antiretroviral therapy; Human immunodeficiency virus (HIV); Intensive care medicine; Viral load; Internal medicine; Nucleoside; Family medicine; Environmental health; Risk analysis (engineering)","authors":[{"name":"Paul Trueman","is_ca":false},{"name":"Mike Youle","is_ca":false},{"name":"Caroline Sabin","is_ca":false},{"name":"Alexander H. Miners","is_ca":false},{"name":"Eduard J. Beck","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2806454061765764,"gpt":0.465997805989622,"spread":0.1853523998130456,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002026544,0.0003485067,0.0005561522,0.000526246,0.0002334655,0.001123809,0.0003420644,0.0007099897,0.002419287],"category_scores_gemma":[0.01168699,0.0002212157,0.0008803764,0.0004416102,0.0003263094,0.000714351,0.0006714797,0.0005896141,0.000112833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004557455,"about_ca_system_score_gemma":0.002018457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.040046,"about_ca_topic_score_gemma":0.03223495,"domain_scores_codex":[0.9977723,0.001677542,0.0001130796,0.0000707127,0.0002437348,0.0001226458],"domain_scores_gemma":[0.9962619,0.00290645,0.0004184837,0.00004445329,0.0002164852,0.0001521458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.009679588,0.0004354501,0.1109178,0.004288172,0.001999173,0.001533475,0.0003530415,0.6762639,0.001401311,0.01087916,0.006759285,0.1754896],"study_design_scores_gemma":[0.004487355,0.008087969,0.2274146,0.006015248,0.003948206,0.004293379,0.001154111,0.7100039,0.003451925,0.01589229,0.01498131,0.0002697021],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9428915,0.03621373,0.005277221,0.004023815,0.000168697,0.0002533977,0.001502411,0.00003655873,0.009632641],"genre_scores_gemma":[0.9960551,0.002627199,0.0007085374,0.00009402342,0.000007486052,0.00003831299,0.0001596791,0.000002229159,0.0003074386],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.040046,"threshold_uncertainty_score":0.07962584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2136451994","doi":"10.1310/7lyw-gqff-wprq-k3qw","title":"Clinical Impact of Double Protease Inhibitor Boosting with Lopinavir/Ritonavir and Amprenavir as Part of Salvage Antiretroviral Therapy","year":2003,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"St. Michael's Hospital; Women's College Hospital; Health Sciences Centre; Canadians Living with HIV; Sunnybrook Health Science Centre; University of Waterloo; University Health Network; University of Toronto; Montreal General Hospital; McGill University","funders":"Abbott Laboratories","keywords":"Lopinavir; Medicine; Amprenavir; Ritonavir; Regimen; Salvage therapy; Internal medicine; Hazard ratio; Atazanavir; Lopinavir/ritonavir; Protease inhibitor (pharmacology); Viral load; Human immunodeficiency virus (HIV); Antiretroviral therapy; Confidence interval; Immunology; Protease; Chemotherapy; HIV-1 protease","authors":[{"name":"Mona Loutfy","is_ca":true},{"name":"Janet Raboud","is_ca":true},{"name":"C. Thompson","is_ca":true},{"name":"Alice Tseng","is_ca":true},{"name":"Zainab Abdurrahman","is_ca":true},{"name":"Colin Kovacs","is_ca":true},{"name":"Anita Rachlis","is_ca":true},{"name":"Elizabeth Phillips","is_ca":true},{"name":"G Rubin","is_ca":false},{"name":"Kevin Gough","is_ca":true},{"name":"Sharon Walmsley","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2044627533897381,"gpt":0.483843551421669,"spread":0.2793807980319309,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009544148,0.0002239485,0.0005133756,0.0001196075,0.0002992241,0.000638827,0.0002337872,0.0003473528,0.00148375],"category_scores_gemma":[0.002741289,0.0001271727,0.0006999219,0.000171279,0.0001712716,0.0002501124,0.0002441818,0.0007897411,0.0001841087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006188729,"about_ca_system_score_gemma":0.0008501318,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001582986,"about_ca_topic_score_gemma":0.00193303,"domain_scores_codex":[0.9993088,0.0001954418,0.00005450678,0.0001402149,0.0001794614,0.0001215594],"domain_scores_gemma":[0.9982595,0.0004357062,0.0006062703,0.00008937762,0.00009398934,0.0005151422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.02726315,0.003647885,0.9008267,0.0001167675,0.0005094021,0.0008192155,0.0001454072,0.0003879189,0.004627092,0.00009048801,0.0005942521,0.06097179],"study_design_scores_gemma":[0.001409168,0.02995154,0.9606789,0.00005943044,0.0005528899,0.001903291,0.0001919168,0.001834803,0.001800812,0.00007061269,0.001530075,0.00001650813],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998964,0.0004889294,0.00004637587,0.00004671238,0.00001270898,0.00001730149,0.00005709969,0.000002932309,0.0003639647],"genre_scores_gemma":[0.999396,0.0001479081,0.00008388975,0.000066187,0.00002093681,0.000008577917,0.0001478653,0.000001152215,0.0001274427],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001582986,"threshold_uncertainty_score":0.0050475,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2048476931","doi":"10.1310/cwd3-dr4k-7ee0-7abl","title":"The Efficacy of Calcium Carbonate in the Treatment of Protease Inhibitor-Induced Persistent Diarrhea in HIV-Infected Patients","year":2004,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Canadian Pharmacists Association; Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Diarrhea; Internal medicine; Visual analogue scale; Calcium carbonate; Calcium; Nelfinavir; Prospective cohort study; Gastroenterology; Human immunodeficiency virus (HIV); Surgery; Immunology; Antiretroviral therapy; Viral load","authors":[{"name":"Turner Megan J.","is_ca":true},{"name":"Jonathan B. Angel","is_ca":false},{"name":"Woodend Kirsten","is_ca":true},{"name":"Pierre Giguère","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1797126751218041,"gpt":0.4497504274225439,"spread":0.2700377523007398,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001392604,0.0002046874,0.0009213857,0.0003161357,0.0002775852,0.0005482312,0.0003531713,0.0005556271,0.000944624],"category_scores_gemma":[0.003792917,0.0001396535,0.0005732736,0.000483266,0.0003177647,0.0003409789,0.0002475235,0.000717974,0.00007516416],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003383046,"about_ca_system_score_gemma":0.0006325693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001033094,"about_ca_topic_score_gemma":0.001868876,"domain_scores_codex":[0.9990889,0.000548413,0.0001099,0.00005308468,0.0001472051,0.0000524828],"domain_scores_gemma":[0.9976808,0.001011267,0.0007983679,0.00006002281,0.0001611655,0.0002883638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4373684,0.01429721,0.1093682,0.00612979,0.002774454,0.0003100718,0.0004042239,0.0007230841,0.01240237,0.0001517141,0.001411865,0.4146585],"study_design_scores_gemma":[0.1152468,0.497518,0.3713995,0.001025399,0.002869301,0.0009398506,0.0003647032,0.001782513,0.004445077,0.0001735141,0.004167423,0.00006791145],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.978302,0.02003431,0.0001039638,0.0002822138,0.00005164988,0.0002810158,0.000130369,0.0000109755,0.0008035167],"genre_scores_gemma":[0.9939069,0.004784992,0.0005324318,0.0001875507,0.00009191425,0.0001252138,0.0001714682,0.000002783482,0.0001967005],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001392604,"threshold_uncertainty_score":0.007364869,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W118439278","doi":"10.1310/m0cv-r6bx-a9dp-jjv0","title":"Circulating Levels of IL-7 but not IL-15, IGF-1, and TGF-β Are Elevated During Primary HIV-1 Infection","year":2004,"lang":"en","type":"letter","venue":"HIV Clinical Trials","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Transforming growth factor; Human immunodeficiency virus (HIV); Immunology; Virology; Internal medicine","authors":[{"name":"Boulassel Mr","is_ca":false},{"name":"Mary‐Anne Young","is_ca":true},{"name":"Routy Jp","is_ca":true},{"name":"Cécile Tremblay","is_ca":true},{"name":"Danielle Rouleau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.144333365076009,"gpt":0.3613578829021454,"spread":0.2170245178261365,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009566023,0.0004273598,0.00123754,0.0002403132,0.000678972,0.001103326,0.0006259391,0.005271896,0.001823961],"category_scores_gemma":[0.005531244,0.000210878,0.0003108309,0.0002338779,0.0007836602,0.0006477652,0.0001634683,0.003912247,0.0009693275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001379248,"about_ca_system_score_gemma":0.0005914887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001093043,"about_ca_topic_score_gemma":0.001986175,"domain_scores_codex":[0.9992531,0.0003462145,0.00007362887,0.00004320771,0.0001505339,0.0001332354],"domain_scores_gemma":[0.9974905,0.001834847,0.0001240891,0.00009200018,0.0002606422,0.0001978109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.01362672,0.0007017323,0.03645834,0.0007979913,0.0002411018,0.06765576,0.0005870141,0.0005751154,0.01904127,0.00382751,0.6298455,0.2266419],"study_design_scores_gemma":[0.005333251,0.007412639,0.1094782,0.0009202038,0.0005679114,0.07428467,0.001349839,0.003574857,0.02265064,0.01260537,0.7616288,0.0001935493],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1530583,0.02221,0.001569292,0.7493504,0.03674619,0.0001859142,0.0004745244,0.0003569537,0.03604836],"genre_scores_gemma":[0.548402,0.008005294,0.001187728,0.3528684,0.06133859,0.0002986229,0.0002256468,0.0000674648,0.02760627],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.005271896,"threshold_uncertainty_score":0.0100072,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069363561","doi":"10.1310/b05e-tfvn-uj8l-mfhj","title":"Attenuated T-Lymphocyte Response to HIV Therapy in Individuals Receiving HMG-CoA Reductase Inhibitors","year":2003,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Fibrate; Ritonavir; Nelfinavir; HMG-CoA reductase; Statin; Rosuvastatin; Atorvastatin; Internal medicine; Saquinavir; Pharmacology; Indinavir; Protease inhibitor (pharmacology); Integrase inhibitor; Viral load; Immunology; Reductase; Antiretroviral therapy; Human immunodeficiency virus (HIV)","authors":[{"name":"Narayan Shanil","is_ca":true},{"name":"Hawley Nanci","is_ca":true},{"name":"Giguère Pierre","is_ca":true},{"name":"Andrew D. Badley","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1986185197320598,"gpt":0.4835371366619322,"spread":0.2849186169298724,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003995971,0.0003326582,0.0004119425,0.0005271942,0.0005157231,0.0005262877,0.0001885808,0.0004267521,0.001220466],"category_scores_gemma":[0.001446035,0.0002436423,0.0003331047,0.0003562144,0.0002387062,0.0002813092,0.0002282582,0.000513494,0.0002595984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002011378,"about_ca_system_score_gemma":0.0001912846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001066203,"about_ca_topic_score_gemma":0.0008301155,"domain_scores_codex":[0.9996785,0.00008705399,0.00002974692,0.00006501266,0.00005311571,0.00008651478],"domain_scores_gemma":[0.9992496,0.0001344185,0.0003011834,0.0000489351,0.00008331105,0.000182588],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001574393,0.0001704185,0.9924982,0.00001575812,0.00005424941,0.0005078804,0.0001034145,0.00006392527,0.002151958,0.00001498338,0.00004902821,0.002795821],"study_design_scores_gemma":[0.00006701152,0.002220513,0.9944074,0.00001268692,0.00008929217,0.00179372,0.0001584349,0.0002758288,0.0005748816,0.00002752676,0.0003660106,0.000006607028],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995633,0.0001462266,0.00003143448,0.00001272915,0.000004746235,0.00000725332,0.00004797214,0.000001837381,0.0001845381],"genre_scores_gemma":[0.9996703,0.00005148565,0.00003761257,0.0000255031,0.00001079111,0.00000619837,0.00008503149,7.777905e-7,0.0001122758],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001220466,"threshold_uncertainty_score":0.004082859,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2094521579","doi":"10.1310/hct1206-313","title":"Effect of Baseline Characteristics on the Efficacy and Safety of Once-Daily Darunavir/ Ritonavir in HIV-1–Infected, Treatment-Naïve ARTEMIS Patients at Week 96","year":2011,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"ACT Government","keywords":"Medicine; Darunavir; Ritonavir; Coinfection; Internal medicine; Incidence (geometry); Adverse effect; Lopinavir; Hepatitis C; Gastroenterology; Human immunodeficiency virus (HIV); Viral load; Immunology; Antiretroviral therapy","authors":[{"name":"Jan Fourie","is_ca":false},{"name":"Jason Flamm","is_ca":false},{"name":"A Rodriguez‐French","is_ca":false},{"name":"Don Kilby","is_ca":true},{"name":"Peré Domingo","is_ca":false},{"name":"Adriano Lazzarin","is_ca":false},{"name":"Juan Ballesteros","is_ca":false},{"name":"Néstor Sosa","is_ca":false},{"name":"Tom Van de Casteele","is_ca":false},{"name":"Ralph DeMasi","is_ca":false},{"name":"Sabrina Spinosa‐Guzman","is_ca":false},{"name":"Ludo Lavreys","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1316770868769122,"gpt":0.3890928780651015,"spread":0.2574157911881892,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001247569,0.0002375417,0.0006714695,0.0001361851,0.0001405206,0.0003914459,0.0001444334,0.0003321268,0.001603492],"category_scores_gemma":[0.003230921,0.0001273399,0.0005736286,0.0001722759,0.0001527836,0.0003683276,0.0001121124,0.0006240306,0.000216374],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002651848,"about_ca_system_score_gemma":0.0002064044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002850384,"about_ca_topic_score_gemma":0.0004895868,"domain_scores_codex":[0.9994164,0.0002720685,0.00006415183,0.0000873488,0.00009374483,0.00006633375],"domain_scores_gemma":[0.9972868,0.001300781,0.0007166719,0.000137804,0.0001403823,0.000417629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2822327,0.006522658,0.5813558,0.0002532928,0.002436348,0.0006510568,0.0003760903,0.00250467,0.0328096,0.0001026477,0.001228706,0.08952637],"study_design_scores_gemma":[0.002580594,0.04612041,0.9433575,0.00002683192,0.0005119193,0.00045645,0.00009401044,0.001912126,0.004131412,0.000061918,0.0007146384,0.00003207843],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992489,0.0003095332,0.00003739226,0.00003263722,0.000008644409,0.00001293804,0.00008353567,0.000003608897,0.000262733],"genre_scores_gemma":[0.9995847,0.00005248181,0.00004334788,0.00003254756,0.00001091435,0.00001250009,0.0001131642,0.000001855322,0.0001485234],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001603492,"threshold_uncertainty_score":0.006597877,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1992656981","doi":"10.1310/hct1006-413","title":"A Systematic Review of the Quality of Trials Evaluating Biomedical HIV Prevention Interventions Shows That Many Lack Power","year":2009,"lang":"en","type":"review","venue":"HIV Clinical Trials","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; Public Health Ontario; Hospital for Sick Children; Institute for Clinical Evaluative Sciences; McGill University; Mount Sinai Hospital; SickKids Foundation; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Medicine; Psychological intervention; Randomized controlled trial; Clinical trial; Systematic review; Human immunodeficiency virus (HIV); Intensive care medicine; MEDLINE; Family medicine; Internal medicine; Psychiatry","authors":[{"name":"Susan M. Graham","is_ca":true},{"name":"Prakesh S. Shah","is_ca":true},{"name":"Zoë Costa-von Aesch","is_ca":true},{"name":"Joseph Beyene","is_ca":true},{"name":"Ahmed M. Bayoumi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.9678022509413752,"gpt":0.8037718717577813,"spread":0.1640303791835939,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2862141,0.002413807,0.01458577,0.007018446,0.001880531,0.008826802,0.003638159,0.004936188,0.004502798],"category_scores_gemma":[0.6854241,0.002466961,0.009510606,0.01209857,0.005863823,0.006239964,0.003180865,0.003280161,0.0006456455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008156966,"about_ca_system_score_gemma":0.01898362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005561556,"about_ca_topic_score_gemma":0.01215557,"domain_scores_codex":[0.5959879,0.2412351,0.1055875,0.01186749,0.04386975,0.001452286],"domain_scores_gemma":[0.1304613,0.7728795,0.06379703,0.00955497,0.02215228,0.00115493],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00134413,0.00005235891,0.008274044,0.7882284,0.04971556,0.0001792059,0.0008865188,0.0007043508,0.0003987741,0.002785193,0.006179896,0.1412517],"study_design_scores_gemma":[0.002565053,0.000968917,0.02789539,0.7657091,0.1466803,0.0009312999,0.001183928,0.0008931208,0.001197437,0.01180442,0.03997137,0.0001997299],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00331761,0.985538,0.003387507,0.004638321,0.0006586121,0.0009085462,0.0004750587,0.00003771982,0.001038612],"genre_scores_gemma":[0.1798996,0.7772406,0.02209723,0.01168217,0.001272093,0.006343646,0.0008200833,0.0001062132,0.0005383667],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7137859,"threshold_uncertainty_score":0.8802252,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1982283413","doi":"10.1310/hct1306-301","title":"Design and Implementation of a Randomized Crossover Study of Valproic Acid and Antiretroviral Therapy to Reduce the HIV Reservoir","year":2012,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"HIV Legal Network; AIDS Vancouver; University of British Columbia; Centre Hospitalier de l’Université de Montréal; Centre hospitalier universitaire de Québec; Ottawa Hospital; University of Ottawa; Royal Victoria Hospital; McGill University Health Centre; Université de Montréal; Royal Victoria Regional Health Centre","funders":"National Institute on Drug Abuse; Ontario HIV Treatment Network","keywords":"Medicine; Crossover study; Valproic Acid; Clinical study design; Clinical trial; Human immunodeficiency virus (HIV); Randomized controlled trial; Crossover; Research design; Oncology; Pharmacology; Internal medicine; Immunology; Epilepsy; Pathology","authors":[{"name":"Jean‐Pierre Routy","is_ca":true},{"name":"Jonathan B. Angel","is_ca":true},{"name":"Johanna N. Spaans","is_ca":true},{"name":"Benoît Trottier","is_ca":false},{"name":"Dominique M. Rouleau","is_ca":true},{"name":"J.G. Baril","is_ca":true},{"name":"Marianne Harris","is_ca":true},{"name":"Sylvie Trottier","is_ca":true},{"name":"Joel Singer","is_ca":true},{"name":"Nicolas Chomont","is_ca":false},{"name":"Rafick‐Pierre Sékaly","is_ca":true},{"name":"Cécile Tremblay","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2416036895497824,"gpt":0.5034676164749569,"spread":0.2618639269251745,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02359429,0.004058609,0.006547426,0.001487336,0.00154647,0.001717929,0.00193444,0.005319961,0.0140433],"category_scores_gemma":[0.01750866,0.001657835,0.002710656,0.001257895,0.003259102,0.001961002,0.001346586,0.003505305,0.001964823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001342157,"about_ca_system_score_gemma":0.00520631,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000582042,"about_ca_topic_score_gemma":0.0005447621,"domain_scores_codex":[0.9797539,0.01265673,0.001666466,0.002576483,0.001488243,0.001858166],"domain_scores_gemma":[0.985752,0.005468021,0.002729233,0.00245624,0.001722609,0.001871882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9397563,0.04469726,0.0007695472,0.0006463493,0.0005527986,0.00005704542,0.0001378316,0.0004771908,0.002233355,0.0005075758,0.0004948718,0.009669896],"study_design_scores_gemma":[0.6868548,0.3078812,0.001514203,0.00005246977,0.0003481519,0.0000165179,0.00003348931,0.0004743326,0.0006791352,0.0004684529,0.001646691,0.00003064419],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"empirical","genre_scores_codex":[0.4220981,0.001489582,0.01146193,0.0008703755,0.003676218,0.5550866,0.001647221,0.0003259473,0.00334401],"genre_scores_gemma":[0.3347716,0.00069887,0.02885659,0.001729319,0.001919137,0.6283399,0.0006072045,0.0000497971,0.003027666],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02359429,"threshold_uncertainty_score":0.12478,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1963635957","doi":"10.1310/hct0902-73","title":"Efficacy and Safety of 48 Weeks of Enfuvirtide 180 mg Once-Daily Dosing Versus 90 mg Twice-Daily Dosing in HIV-Infected Patients","year":2008,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tolerability; Enfuvirtide; Dosing; Regimen; Adverse effect; Pharmacokinetics; Internal medicine; Pharmacology; Immunology","authors":[{"name":"David H. Wright","is_ca":false},{"name":"Allen E. Rodriguez","is_ca":false},{"name":"Eliot Godofsky","is_ca":false},{"name":"Sharon Walmsley","is_ca":true},{"name":"Emily Labriola–Tompkins","is_ca":false},{"name":"Lucille Donatacci","is_ca":false},{"name":"Anna Shikhman","is_ca":false},{"name":"Ernestine Tucker","is_ca":false},{"name":"Yu-Yuan Chiu","is_ca":false},{"name":"Jain Chung","is_ca":false},{"name":"Lucy Rowell","is_ca":false},{"name":"Ralph DeMasi","is_ca":false},{"name":"Neil M.H. Graham","is_ca":false},{"name":"Miklos Salgo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1454580302820737,"gpt":0.408940599363976,"spread":0.2634825690819023,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001032363,0.0006911956,0.001455093,0.0002148054,0.0002654575,0.0005268561,0.0004099237,0.000958864,0.002700126],"category_scores_gemma":[0.001782979,0.0004115067,0.0008215036,0.000161246,0.0004155439,0.0007954543,0.0002240239,0.001227255,0.0003991246],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004538272,"about_ca_system_score_gemma":0.0004203393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004039728,"about_ca_topic_score_gemma":0.0007126691,"domain_scores_codex":[0.9994917,0.0002545914,0.00003640226,0.0001018021,0.00005525304,0.00006013067],"domain_scores_gemma":[0.9991504,0.0002192101,0.0003048322,0.00005645237,0.00003504786,0.000234089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8528908,0.01596191,0.006727071,0.0003905777,0.0005276569,0.00009636961,0.0001471467,0.00103975,0.01728689,0.00007872468,0.0006359761,0.104217],"study_design_scores_gemma":[0.259198,0.6858124,0.04627126,0.00006519536,0.0005975053,0.0002550217,0.00009242097,0.002406914,0.003978084,0.0001977151,0.001071686,0.00005386108],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977349,0.001339022,0.0001001603,0.00009988438,0.00003677935,0.0001261001,0.000100265,0.0000236702,0.0004392072],"genre_scores_gemma":[0.9985228,0.0003402083,0.0002770515,0.0001440505,0.00005394625,0.0001620777,0.0001155262,0.000004476122,0.0003799202],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002700126,"threshold_uncertainty_score":0.009032786,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W2085670377","doi":"10.1310/hct1504-161","title":"Citalopram for the Prevention of Depression and Its Consequences in HIV-Hepatitis C Coinfected Individuals Initiating Pegylated Interferon/Ribavirin Therapy: A Multicenter Randomized Double-Blind Placebo-Controlled Trial","year":2014,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McMaster University Medical Centre; University Health Network; Ottawa Hospital; Vancouver Infectious Diseases Centre; Université de Montréal; AIDS Vancouver; Concordia University; McGill University Health Centre; McGill University; HIV Legal Network; University of Toronto; Royal Victoria Hospital","funders":"","keywords":"Medicine; Ribavirin; Citalopram; Internal medicine; Placebo; Randomized controlled trial; Hepatitis C; Depression (economics); Pegylated interferon; Hepatitis C virus; Immunology; Antidepressant","authors":[{"name":"Marina B. Klein","is_ca":true},{"name":"Terry Lee","is_ca":true},{"name":"Marie‐Josée Brouillette","is_ca":true},{"name":"Nancy L. Sheehan","is_ca":true},{"name":"Sharon Walmsley","is_ca":true},{"name":"David Wong","is_ca":true},{"name":"Brian Conway","is_ca":true},{"name":"Mark Hull","is_ca":true},{"name":"Curtis Cooper","is_ca":true},{"name":"Shariq Haidar","is_ca":true},{"name":"Sylvie Vézina","is_ca":true},{"name":"L Annable","is_ca":true},{"name":"Simon N. Young","is_ca":true},{"name":"Wendy Zubyk","is_ca":true},{"name":"Joel Singer","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2860303912486745,"gpt":0.5005123531631583,"spread":0.2144819619144839,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001709318,0.001170669,0.003115028,0.0004504942,0.0006202562,0.001008055,0.0008694184,0.001969922,0.004452098],"category_scores_gemma":[0.002061255,0.0006875281,0.001723663,0.0006006904,0.00096422,0.0005900301,0.0002864294,0.001803192,0.0004221216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009604797,"about_ca_system_score_gemma":0.001853665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004934156,"about_ca_topic_score_gemma":0.009105541,"domain_scores_codex":[0.9993635,0.0003182707,0.00006285696,0.0000991745,0.00006925115,0.00008693788],"domain_scores_gemma":[0.9991342,0.0002469557,0.0002256351,0.00005437064,0.00009726385,0.0002415898],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9792741,0.003575796,0.0004008052,0.001190764,0.0009239066,0.00003278624,0.00004076898,0.00008673007,0.00200564,0.00004805611,0.0003338768,0.01208674],"study_design_scores_gemma":[0.9739504,0.0236652,0.001253781,0.00004702014,0.0005377494,0.00001615652,0.00001100253,0.0001247596,0.0001714542,0.00002291703,0.0001921915,0.000007222383],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9714916,0.01730815,0.0005128871,0.001008105,0.0008560869,0.006427125,0.0007737044,0.0001139864,0.001508294],"genre_scores_gemma":[0.9793707,0.01055843,0.001715484,0.0009091599,0.0008122438,0.00421012,0.0004774794,0.00001627256,0.001930137],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004934156,"threshold_uncertainty_score":0.01489377,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068355743","doi":"10.1310/hct0905-314","title":"A Prospective Study of Body Fat Redistribution, Lipid, and Glucose Parameters in HIV-Infected Patients Initiating Combination Antiretroviral Therapy","year":2008,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto; McMaster University Medical Centre; University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Lipodystrophy; Medicine; Prospective cohort study; Internal medicine; Triglyceride; Endocrinology; Antiretroviral therapy; Waist; Lipoatrophy; Diabetes mellitus; Anthropometry; Lipid profile; Stavudine; Metabolic syndrome; Insulin; Human immunodeficiency virus (HIV); Gastroenterology; Cholesterol; Body mass index; Viral load; Immunology","authors":[{"name":"Sharon Walmsley","is_ca":true},{"name":"Angela M. Cheung","is_ca":true},{"name":"George Fantus","is_ca":true},{"name":"Kevin Gough","is_ca":true},{"name":"Fiona Smaill","is_ca":true},{"name":"AK Azad","is_ca":true},{"name":"Christina Diong","is_ca":true},{"name":"Janet Raboud","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1445983891358264,"gpt":0.4386299770869479,"spread":0.2940315879511215,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005559869,0.0004202458,0.0004838364,0.0005956341,0.0008768844,0.0007790851,0.0002851398,0.0006208358,0.001426096],"category_scores_gemma":[0.001659214,0.0005878116,0.0003572042,0.000923367,0.0002480858,0.0005565619,0.0003154411,0.001021223,0.0003722796],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002233423,"about_ca_system_score_gemma":0.0003941946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003075188,"about_ca_topic_score_gemma":0.003355524,"domain_scores_codex":[0.9995611,0.0001195263,0.00004474365,0.00009478899,0.00009444088,0.0000852798],"domain_scores_gemma":[0.998832,0.0001809199,0.0004297328,0.0001067728,0.0001306308,0.0003199439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001211639,0.00006127144,0.999073,0.000003536762,0.00002225197,0.00007256711,0.00003979972,0.00001117295,0.0001476438,0.00000332922,0.00002955547,0.0004146394],"study_design_scores_gemma":[0.00002291859,0.0004243454,0.9984982,0.000005828413,0.00002537754,0.0005800435,0.0001333498,0.00009500342,0.00004996084,0.000007208573,0.0001537793,0.000004024457],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992697,0.0001332288,0.00005816748,0.0000196805,0.000005313894,0.00001766115,0.0002831386,0.000002503403,0.0002105758],"genre_scores_gemma":[0.9992297,0.00007968003,0.0001053292,0.00003785922,0.00001057044,0.00002074888,0.0003687674,0.000001777133,0.0001455257],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003075188,"threshold_uncertainty_score":0.006114542,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1999280643","doi":"10.1310/hct0705-251","title":"Infection Rates in HIV-HCV Patients Treated with Interferon Are Similar to Those in HCV Mono-Infection and Not Related to Neutropenia","year":2006,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Neutropenia; Human immunodeficiency virus (HIV); Interferon; Infection rate; Internal medicine; Immunology; Ribavirin; Hepatitis C virus; Virus; Surgery; Chemotherapy","authors":[{"name":"Curtis Cooper","is_ca":true},{"name":"Saif Al-Bedwawi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1741195540349859,"gpt":0.4748693181522344,"spread":0.3007497641172485,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008321754,0.000126782,0.0002739567,0.0002808625,0.0002064337,0.0003133535,0.0001063844,0.0003331479,0.001525098],"category_scores_gemma":[0.003764362,0.000141412,0.0002049881,0.0002057395,0.0001767034,0.0001832033,0.0001336381,0.0003314988,0.0001511795],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002162989,"about_ca_system_score_gemma":0.000203382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007272582,"about_ca_topic_score_gemma":0.001292784,"domain_scores_codex":[0.9994024,0.0003305192,0.00005625333,0.00004540889,0.00009918376,0.00006624698],"domain_scores_gemma":[0.9975395,0.000777981,0.001280318,0.0000928377,0.00009591449,0.0002133172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002878995,0.0002334701,0.9844624,0.00004853113,0.0001107942,0.000276729,0.0001145324,0.0001492225,0.001703639,0.0000470013,0.0001792528,0.009795395],"study_design_scores_gemma":[0.0002157851,0.001562421,0.9957114,0.00002001609,0.00005290917,0.001209554,0.00008933571,0.0002449756,0.0005390421,0.00004727416,0.0002991334,0.000008027801],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991371,0.0004229428,0.0000432638,0.00002618837,0.000002915694,0.000013674,0.00005533535,0.000001660502,0.0002969622],"genre_scores_gemma":[0.9995529,0.0001140182,0.00008690594,0.00002171027,0.000005931307,0.00001062878,0.0001212135,6.370185e-7,0.00008596491],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001525098,"threshold_uncertainty_score":0.005101979,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122378285","doi":"10.1310/hct0806-421","title":"Evaluation of Stool Frequency and Stool Form as Measures of HIV-Related Diarrhea","year":2007,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network; Mount Sinai Hospital; Health Sciences Centre; Sinai Health System; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"University of Toronto; Innovative Research Group Project of the National Natural Science Foundation of China; University Health Network","keywords":"Diarrhea; Medicine; Internal medicine; Human immunodeficiency virus (HIV); Gastroenterology; Prospective cohort study; Antiretroviral therapy; Correlation; Viral load; Immunology","authors":[{"name":"Jill Tinmouth","is_ca":true},{"name":"George Tomlinson","is_ca":true},{"name":"Gabor Kandel","is_ca":true},{"name":"Sharon Walmsley","is_ca":true},{"name":"Hillary Steinhart","is_ca":true},{"name":"Richard H. Glazier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3488472668489003,"gpt":0.5262927517135569,"spread":0.1774454848646567,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002697437,0.0005527251,0.000493553,0.0007277401,0.0002412947,0.0004490748,0.0002694347,0.000274795,0.001035263],"category_scores_gemma":[0.007425434,0.0001381807,0.0003775895,0.0007066827,0.0003590812,0.0005168387,0.0004036058,0.0003552969,0.0001338127],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001822067,"about_ca_system_score_gemma":0.0002851382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006318279,"about_ca_topic_score_gemma":0.0009270629,"domain_scores_codex":[0.9982136,0.001285807,0.0001334287,0.0001082825,0.0002105037,0.00004842117],"domain_scores_gemma":[0.9953556,0.001782688,0.002088158,0.0001947895,0.0003263934,0.0002524545],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004739018,0.0001020104,0.9922271,0.00004189246,0.0001001305,0.00001454871,0.00003170679,0.0001108026,0.00022577,0.000010466,0.00003173904,0.006629991],"study_design_scores_gemma":[0.00003750901,0.002700211,0.9954785,0.00002160474,0.00007996017,0.000215225,0.00007509837,0.0008687739,0.0003223234,0.0000399062,0.0001540439,0.000006944917],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997733,0.001101358,0.0005396098,0.00003620938,0.000006703999,0.00004877116,0.0001821272,0.000007616684,0.0003446895],"genre_scores_gemma":[0.9984152,0.0002414166,0.000927958,0.00001967119,0.000008573627,0.00004266356,0.0002091645,0.000001406349,0.0001338754],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002697437,"threshold_uncertainty_score":0.0142656,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239380123","doi":"10.1310/hct1301-023","title":"High-Level Immunogenicity Is Achieved Vaccine With Adjuvanted Pandemic H1N1&lt;sub&gt;2009&lt;/sub&gt; and Improved With Booster Dosing in a Randomized Trial of HIV-Infected Adults","year":2012,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Public Health Agency of Canada; University of British Columbia; Dalhousie University; University of Toronto; McGill University; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Immunogenicity; Seroconversion; Dosing; Booster dose; Booster (rocketry); Immunology; Live attenuated influenza vaccine; Influenza vaccine; Immunization; Internal medicine; Vaccination; Virology; Antigen; Human immunodeficiency virus (HIV)","authors":[{"name":"Curtis Cooper","is_ca":true},{"name":"Marina B. Klein","is_ca":true},{"name":"Sharon Walmsley","is_ca":true},{"name":"David Haase","is_ca":true},{"name":"Donna MacKinnon‐Cameron","is_ca":true},{"name":"Kim Marty","is_ca":true},{"name":"Yan Li","is_ca":false},{"name":"Bruce R. Smith","is_ca":true},{"name":"Scott A. Halperin","is_ca":true},{"name":"Barb Law","is_ca":true},{"name":"David W. Scheifele","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1541682413321429,"gpt":0.4268660800435144,"spread":0.2726978387113715,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002714179,0.0008950074,0.001280027,0.0002504254,0.0003364955,0.0008031628,0.0005762503,0.001134691,0.00407797],"category_scores_gemma":[0.001594424,0.0005279568,0.001136513,0.0001953392,0.0009197807,0.0007759106,0.0003439733,0.002256012,0.0004933724],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005473549,"about_ca_system_score_gemma":0.0008899973,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005974752,"about_ca_topic_score_gemma":0.0009892192,"domain_scores_codex":[0.9991284,0.0005349052,0.00006601145,0.0001056688,0.00006172674,0.0001033952],"domain_scores_gemma":[0.9987627,0.0003116108,0.0003453006,0.0001074614,0.00007980908,0.000393207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9680217,0.01273421,0.002033754,0.0002937054,0.0008514394,0.00002180155,0.00006511471,0.0001781057,0.003798359,0.00006728632,0.0004809337,0.01145357],"study_design_scores_gemma":[0.8027619,0.1882779,0.005873937,0.00003958813,0.0006473762,0.00003455435,0.00002538356,0.0004068965,0.001436221,0.00008857039,0.0003966436,0.00001098453],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971045,0.0007778913,0.0002020433,0.0002288135,0.0001368461,0.0008459414,0.0001396081,0.00002587299,0.0005385768],"genre_scores_gemma":[0.9968846,0.000411574,0.0006369764,0.0003457365,0.0001542898,0.0008036644,0.0001778468,0.000006941567,0.0005782546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00407797,"threshold_uncertainty_score":0.01435411,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2105543437","doi":"10.1179/1528433614z.0000000015","title":"Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: results from the VERITAS study (TMC114HIV4054)","year":2015,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Regimen; Lamivudine; Adverse effect; Emtricitabine; Internal medicine; Viral load; Surgery; Gastroenterology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Virology; Chronic hepatitis","authors":[{"name":"Benoît Trottier","is_ca":false},{"name":"Chrissi Galanakis","is_ca":false},{"name":"Danièle Longpré","is_ca":false},{"name":"Harold Dion","is_ca":false},{"name":"Sylvie Vézina","is_ca":false},{"name":"Stéphane Lavoie","is_ca":false},{"name":"Michel Boissonnault","is_ca":false},{"name":"Cecilia T. Costiniuk","is_ca":true},{"name":"Mohammad-Ali Jenabian","is_ca":true},{"name":"Nimâ Machouf","is_ca":false},{"name":"Réjean Thomas","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3198417514449129,"gpt":0.4775088242655605,"spread":0.1576670728206476,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003389711,0.0006100336,0.0009613296,0.0002052649,0.0002422165,0.0006552931,0.0007403578,0.0007748307,0.003825648],"category_scores_gemma":[0.002055549,0.0002433519,0.0009681244,0.0002262613,0.0005827528,0.0005655937,0.0002417711,0.001839376,0.0004302918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004163893,"about_ca_system_score_gemma":0.0008085088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001113978,"about_ca_topic_score_gemma":0.001985279,"domain_scores_codex":[0.9991027,0.0005194987,0.00005157905,0.0000959024,0.0001112098,0.0001191111],"domain_scores_gemma":[0.9977956,0.0007740155,0.0005461628,0.0001791668,0.0001429221,0.0005621258],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7327416,0.03461435,0.02572951,0.0006461566,0.002232,0.0002279934,0.0002711825,0.001615336,0.02043153,0.0001533396,0.003153281,0.1781838],"study_design_scores_gemma":[0.3929181,0.5333108,0.06469133,0.0001208167,0.001843309,0.0003544853,0.00009899084,0.001331836,0.003054259,0.0001270397,0.002105262,0.00004379938],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966558,0.001695236,0.0001259904,0.0002383226,0.00004631344,0.0001917242,0.0004088422,0.00002685329,0.0006108218],"genre_scores_gemma":[0.9953744,0.001152221,0.0005273308,0.0004516164,0.0001343743,0.0001585474,0.001309265,0.00001262449,0.000879749],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003825648,"threshold_uncertainty_score":0.01792675,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965528887","doi":"10.1310/q2l2-qvrk-4e01-c8f8","title":"Progression to AIDS or Death as Endpoints in HIV Clinical Trials","year":2001,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"Styrelsen för Internationellt Utvecklingssamarbete","keywords":"Medicine; Regimen; Internal medicine; Clinical endpoint; Clinical trial; Cohort; Antiretroviral therapy; Human immunodeficiency virus (HIV); Protease inhibitor (pharmacology); Viral load; Oncology; Immunology","authors":[{"name":"François Raffi","is_ca":true},{"name":"Geneviève Chêne","is_ca":false},{"name":"R. Lassalle","is_ca":false},{"name":"Thierry May","is_ca":false},{"name":"Eric Billaud","is_ca":false},{"name":"Hervé Fleury","is_ca":false},{"name":"P. Dellamonica","is_ca":true},{"name":"Catherine Leport","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5056012280870779,"gpt":0.6012395459815103,"spread":0.09563831789443245,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1335914,0.002031987,0.005078463,0.002770383,0.0008143019,0.003194884,0.001256041,0.003212739,0.003211783],"category_scores_gemma":[0.1464954,0.000638682,0.003830205,0.003312293,0.002198826,0.002454446,0.0019919,0.00302048,0.0004292533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001460014,"about_ca_system_score_gemma":0.002682104,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002415921,"about_ca_topic_score_gemma":0.0004337545,"domain_scores_codex":[0.7219256,0.2577569,0.01082006,0.003134955,0.005487415,0.0008751299],"domain_scores_gemma":[0.7931687,0.1602455,0.03346263,0.004563003,0.004426273,0.004133837],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.6885417,0.002189752,0.07400732,0.03296022,0.03092756,0.0004010702,0.0006157134,0.0083287,0.001184491,0.007328627,0.007229313,0.1462856],"study_design_scores_gemma":[0.4330463,0.2332568,0.1537949,0.01401375,0.02552301,0.002146258,0.0007563541,0.04077253,0.004406441,0.02251601,0.06928201,0.0004857295],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5202827,0.3605631,0.03108012,0.007933839,0.00270936,0.0481658,0.00896609,0.0005291179,0.01976981],"genre_scores_gemma":[0.8664512,0.02425242,0.02496793,0.002661179,0.0013583,0.07352278,0.003477908,0.0001177259,0.003190552],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1335914,"threshold_uncertainty_score":0.7065073,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068181643","doi":"10.1310/hct0805-311","title":"An Estimate of the Proportion of Symptoms Reported in Self-Administered Questionnaires That Are Captured as Adverse Drug Events in an Observational Database","year":2007,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network","funders":"Ontario HIV Treatment Network","keywords":"Medicine; Interquartile range; Diarrhea; Nausea; Adverse effect; Cohort; Observational study; Cohort study; Pediatrics; Internal medicine","authors":[{"name":"Janet Raboud","is_ca":true},{"name":"Maia Lesosky","is_ca":true},{"name":"Sherine Sterling","is_ca":true},{"name":"Elizabeth Phillips","is_ca":false},{"name":"Sharon Walmsley","is_ca":true},{"name":"Ahmed M. Bayoumi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5661113770237269,"gpt":0.6173921826787941,"spread":0.05128080565506721,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02488728,0.000492527,0.0007700682,0.003771533,0.0004685346,0.001487418,0.00117087,0.0009274769,0.00094742],"category_scores_gemma":[0.08048438,0.0004990092,0.001280916,0.003946918,0.0003912668,0.001537338,0.00116045,0.0006853143,0.0004050122],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00132162,"about_ca_system_score_gemma":0.0009234692,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01460376,"about_ca_topic_score_gemma":0.00844197,"domain_scores_codex":[0.9694682,0.01616062,0.004743591,0.003585787,0.005327022,0.0007147588],"domain_scores_gemma":[0.9023899,0.04203292,0.0368924,0.007596232,0.01018959,0.0008989853],"domain_codex":null,"domain_gemma":"reporting","domain_candidate":"reporting","domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00007308515,0.00001691616,0.9968982,0.00007551926,0.0003354557,0.00001440362,0.00006552978,0.0001047613,0.00008539021,0.00004222601,0.0002433283,0.002045202],"study_design_scores_gemma":[0.0000166908,0.00009372067,0.9961095,0.00006473585,0.0001759864,0.0002788366,0.0001399514,0.001951386,0.0001491318,0.00005143846,0.0009573681,0.00001112058],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9494499,0.002606912,0.01805537,0.0004957124,0.00008951508,0.0005865609,0.02588207,0.00009482444,0.002739116],"genre_scores_gemma":[0.9816509,0.0006185413,0.004543258,0.0003233952,0.00009760627,0.0005394694,0.01189385,0.00001615393,0.0003167278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9751127,"threshold_uncertainty_score":0.1316181,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143379599","doi":"10.1310/fgmf-y0ly-dmx8-371v","title":"Predictors of Long-Term Immunological Outcome in Rebounding Patients on Protease Inhibitor-Based HAART After Initial Successful Virologic Suppression: Implications for Timing to Switch","year":2003,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"McMaster University; Bayer Corporation","keywords":"Medicine; Viremia; Viral load; Internal medicine; Protease inhibitor (pharmacology); Univariate analysis; Gastroenterology; Reverse-transcriptase inhibitor; Immunology; Retrospective cohort study; Multivariate analysis; Area under the curve; Human immunodeficiency virus (HIV); Antiretroviral therapy","authors":[{"name":"Lina Rachele Tomasoni","is_ca":false},{"name":"A. Patroni","is_ca":false},{"name":"Carlo Torti","is_ca":false},{"name":"Giuseppe Paraninfo","is_ca":false},{"name":"Francesco Gargiulo","is_ca":false},{"name":"Eugenia Quirós-Roldán","is_ca":false},{"name":"Maria Cristina Uccelli","is_ca":false},{"name":"Paolo Airó","is_ca":false},{"name":"Carmine Tinelli","is_ca":false},{"name":"Giampiero Carosi","is_ca":false},{"name":"Francesco Castelli","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.220466695654694,"gpt":0.4709658042581454,"spread":0.2504991086034514,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006797098,0.000291504,0.000282949,0.000378019,0.0002319475,0.0004885424,0.0002620641,0.0004885386,0.0011643],"category_scores_gemma":[0.002982005,0.0001381989,0.0003148417,0.0003727244,0.000246613,0.0003421606,0.000214965,0.0005813088,0.0002399507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001737105,"about_ca_system_score_gemma":0.0002449445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009236733,"about_ca_topic_score_gemma":0.0008037002,"domain_scores_codex":[0.9997556,0.00007776344,0.00003001592,0.00004323039,0.00003677544,0.00005660762],"domain_scores_gemma":[0.9975744,0.000721404,0.001006512,0.00007450666,0.0001399951,0.0004832461],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002506197,0.0000248026,0.9986569,0.000003211836,0.00001288117,0.00006347702,0.00001316953,0.00004763091,0.0001349333,0.00000344403,0.00002269265,0.0007661178],"study_design_scores_gemma":[0.00001426989,0.0002908756,0.9985871,0.000006415256,0.00002181511,0.0004262552,0.00006995862,0.0004115326,0.00007825287,0.00001237649,0.00007865997,0.000002531809],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995547,0.000231445,0.00003777663,0.00003210553,0.000003406898,0.000002841172,0.00003878295,0.00000153551,0.00009725746],"genre_scores_gemma":[0.9997728,0.00004545082,0.00003240825,0.000008754364,0.00001061199,0.00000236024,0.00008482856,7.976958e-7,0.00004198373],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0011643,"threshold_uncertainty_score":0.003894925,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2317708264","doi":"10.1310/hct1302-90","title":"Relationship of Chronic Hepatitis C Infection to Rates of AIDS-Defining Illnesses in a Canadian Cohort of HIV Seropositive Individuals Receiving Highly Active Antiretroviral Therapy","year":2012,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Hepatitis C virus research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"St. Michael's Hospital; University of Ottawa; Simon Fraser University; McGill University; McGill University Health Centre; Ontario HIV Treatment Network; Women's College Hospital; Maple Leaf Medical Clinic; Public Health Ontario; Canadian AIDS Treatment Information Exchange; St. Paul's Hospital; University of British Columbia; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Multicenter AIDS Cohort Study; Cohort; Internal medicine; Hepatitis C virus; Immunology; Rate ratio; Poisson regression; Hepatitis C; Cohort study; Relative risk; Viral disease; Virology; Human immunodeficiency virus (HIV); Sida; Confidence interval; Virus; Population; Environmental health","authors":[{"name":"Janet Raboud","is_ca":true},{"name":"Aranka Anema","is_ca":true},{"name":"DeSheng Su","is_ca":true},{"name":"Marina B. Klein","is_ca":true},{"name":"Anush Zakaryan","is_ca":true},{"name":"Tracy Swan","is_ca":false},{"name":"Andrew Palmer","is_ca":true},{"name":"Sean R Hosein","is_ca":true},{"name":"Mona Loutfy","is_ca":true},{"name":"Nimâ Machouf","is_ca":false},{"name":"Julio Montaner","is_ca":true},{"name":"Sean B. Rourke","is_ca":true},{"name":"Chris Tsoukas","is_ca":true},{"name":"Robert S. Hogg","is_ca":true},{"name":"Curtis Cooper","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1866082505449775,"gpt":0.4777872682201085,"spread":0.291179017675131,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008171359,0.000450929,0.0004434553,0.00149565,0.002118286,0.001216601,0.001384681,0.0006206855,0.002554654],"category_scores_gemma":[0.00298967,0.0005059266,0.0009396645,0.002204682,0.0005334868,0.0003425778,0.0007182416,0.001008909,0.0001786683],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01064239,"about_ca_system_score_gemma":0.01539826,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9815931,"about_ca_topic_score_gemma":0.9697128,"domain_scores_codex":[0.9991758,0.00005516151,0.00004301657,0.0001605808,0.0003144251,0.0002509229],"domain_scores_gemma":[0.9975411,0.0001581294,0.0006209601,0.0001246528,0.001003469,0.0005517917],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00007327683,0.00001479316,0.9980583,0.00001157408,0.00005889616,0.00004201306,0.0001221644,0.00006638571,0.00008597343,0.00003518386,0.0003586226,0.001072734],"study_design_scores_gemma":[0.000008021651,0.00002443053,0.9987797,0.00001404577,0.00004133063,0.0001115229,0.0002283013,0.0003873725,0.00002548094,0.00001708096,0.0003524788,0.00001028771],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942628,0.0008832813,0.00010031,0.000300101,0.00001451712,0.00003218872,0.00282235,0.00001490612,0.001569549],"genre_scores_gemma":[0.9982288,0.0003896264,0.000118901,0.00004489909,0.000006492237,0.000008634365,0.0008569668,0.000003614798,0.0003419693],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01840693,"threshold_uncertainty_score":0.07721633,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971304024","doi":"10.1310/hct0801-36","title":"Virologic and Immunologic Impact and Durability of Enfuvirtide-Based Antiretroviral Therapy in HIV-Infected Treatment-Experienced Patients in a Clinical Setting","year":2007,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital; Maple Leaf Medical Clinic","funders":"Canadian Institutes of Health Research","keywords":"Enfuvirtide; Medicine; Interquartile range; Viral load; Discontinuation; Internal medicine; Regimen; Hazard ratio; Retrospective cohort study; Adverse effect; Salvage therapy; Gastroenterology; Human immunodeficiency virus (HIV); Confidence interval; Immunology; Chemotherapy","authors":[{"name":"Mona Loutfy","is_ca":true},{"name":"Tony Antoniou","is_ca":true},{"name":"Shuhang Shen","is_ca":true},{"name":"Christina Diong","is_ca":true},{"name":"Mihaela Bustuchina ̆ Vlaicu","is_ca":false},{"name":"Roberta Halpenny","is_ca":true},{"name":"Colin Kovacs","is_ca":true},{"name":"David Fletcher","is_ca":true},{"name":"J. Raboud","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1303890675655805,"gpt":0.4729908189783467,"spread":0.3426017514127663,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001869595,0.0002233569,0.000431226,0.0001902473,0.0003008994,0.0007227713,0.0002096109,0.0003417473,0.001002431],"category_scores_gemma":[0.005481718,0.0001571024,0.0002823117,0.0002844379,0.000243489,0.0003662794,0.0002211719,0.0003958129,0.0001460289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002551827,"about_ca_system_score_gemma":0.0003214412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003967588,"about_ca_topic_score_gemma":0.0006198213,"domain_scores_codex":[0.9988512,0.0006137564,0.00012124,0.000121176,0.0001961315,0.00009660407],"domain_scores_gemma":[0.9958912,0.001136203,0.002225408,0.0001057253,0.0002498803,0.0003915634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003828101,0.0002185062,0.9875718,0.00005567172,0.0001489604,0.0001451449,0.00004232669,0.0001271989,0.001006269,0.00001669849,0.00009553978,0.006743699],"study_design_scores_gemma":[0.0002555163,0.003424641,0.9934918,0.00002458234,0.0001088235,0.001149414,0.0001008934,0.0005975293,0.0004915306,0.00003198836,0.000314078,0.000009077555],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989545,0.0006883178,0.00003810445,0.00002600972,0.000002706269,0.000009829489,0.0000701551,0.000001626867,0.0002086563],"genre_scores_gemma":[0.9996346,0.0001012089,0.00006651841,0.0000308977,0.00001226508,0.000005622903,0.0001084576,7.198551e-7,0.0000397223],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001869595,"threshold_uncertainty_score":0.009887457,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2023936662","doi":"10.1310/hct1306-357","title":"Physician Attitudes Regarding Pregnancy, Fertility Care, and Assisted Reproductive Technologies for HIV-Infected Individuals and Couples","year":2012,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Reproductive Health and Technologies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Women's College Hospital; University of British Columbia Hospital; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Fertility; Medicine; Assisted reproductive technology; Family medicine; Pregnancy; Population; Logistic regression; Reproductive medicine; Reproductive health; Fertility clinic; Gynecology; Infertility; Environmental health","authors":[{"name":"Mark H. Yudin","is_ca":true},{"name":"Deborah Money","is_ca":true},{"name":"Matthew C. Cheung","is_ca":true},{"name":"Mona Loutfy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2701846422825666,"gpt":0.4840508541485525,"spread":0.2138662118659859,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009536317,0.00008205466,0.0000759703,0.0003024135,0.0005742107,0.00033922,0.0001441591,0.000265138,0.002283263],"category_scores_gemma":[0.004705033,0.00007742742,0.0001243398,0.000283645,0.0004087466,0.0002130207,0.0001903516,0.0002507389,0.0001255946],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009078312,"about_ca_system_score_gemma":0.001637838,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.08450336,"about_ca_topic_score_gemma":0.1468008,"domain_scores_codex":[0.999378,0.0002114993,0.00003394399,0.00003505123,0.0002465481,0.0000949906],"domain_scores_gemma":[0.9968299,0.0009372671,0.000955826,0.00004425515,0.0004784383,0.0007542768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003053961,0.00004562461,0.9900539,0.00003482064,0.00001427647,0.0000827508,0.001496481,0.00005467398,0.0002119243,0.00003293863,0.0004396031,0.007502346],"study_design_scores_gemma":[0.000005123512,0.00010473,0.9965108,0.00003875148,0.00001250726,0.0003375654,0.00180985,0.00009608836,0.00007007009,0.00001726007,0.000994029,0.00000328259],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965606,0.0004400611,0.00005030086,0.0006077116,0.00000807005,0.00001127363,0.00005854835,0.000002001953,0.002261431],"genre_scores_gemma":[0.9985704,0.0005652879,0.0001113697,0.000292239,0.00001251883,0.000005439495,0.00005282983,4.514781e-7,0.0003894883],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08450336,"threshold_uncertainty_score":0.168023,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097226982","doi":"10.1310/hct1206-323","title":"Four-Year Follow-Up of Polyalkylimide Gel Use for the Treatment of HIV-Associated Lipoatrophy","year":2011,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadians Living with HIV; University of Toronto; University Health Network; St. Michael's Hospital; Maple Leaf Medical Clinic; Women's College Hospital","funders":"","keywords":"Medicine; Anxiety; Depression (economics); Randomized controlled trial; Quality of life (healthcare); Internal medicine; Lipoatrophy; Human immunodeficiency virus (HIV); Patient satisfaction; Physical therapy; Surgery; Viral load; Antiretroviral therapy; Psychiatry; Immunology","authors":[{"name":"Mona Loutfy","is_ca":true},{"name":"Jason Brunetta","is_ca":true},{"name":"Colin Kovacs","is_ca":true},{"name":"Christina Diong","is_ca":true},{"name":"Molly Gamble","is_ca":true},{"name":"Tony Antoniou","is_ca":true},{"name":"Graham Smith","is_ca":true},{"name":"Roberta Halpenny","is_ca":true},{"name":"Ron Rosenes","is_ca":true},{"name":"Janet Raboud","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5745653611812509,"gpt":0.4586381917043282,"spread":0.1159271694769227,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004272368,0.0005303047,0.001428506,0.0004117782,0.0005790692,0.0006017356,0.0004571971,0.001271764,0.002680119],"category_scores_gemma":[0.004980041,0.0003305782,0.001564795,0.0003478333,0.0004790339,0.0008153186,0.0004345182,0.001468594,0.0002823593],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005492917,"about_ca_system_score_gemma":0.000762161,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001068129,"about_ca_topic_score_gemma":0.001363575,"domain_scores_codex":[0.9981845,0.001005668,0.0001913297,0.0001860832,0.0001928934,0.000239444],"domain_scores_gemma":[0.9971114,0.0007690594,0.001273918,0.0001783646,0.0002839666,0.0003832659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7884945,0.02863954,0.07853718,0.001531281,0.003791319,0.0002209016,0.0003530233,0.0005646032,0.004903524,0.0000795735,0.0008354272,0.09204924],"study_design_scores_gemma":[0.1372291,0.5920087,0.2590247,0.0002374437,0.005453443,0.0001929378,0.0002307384,0.0008524655,0.002804734,0.000101811,0.00180306,0.00006084446],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953911,0.003002404,0.0001320373,0.0001073787,0.0000602437,0.0005230828,0.0002556418,0.00001094971,0.0005171341],"genre_scores_gemma":[0.9975883,0.000656293,0.0002453057,0.0001416153,0.00007005881,0.00054036,0.0003155752,0.000002018116,0.0004405979],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004272368,"threshold_uncertainty_score":0.02259475,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2020067315","doi":"10.1310/95ve-a6kj-wrq0-1f8y","title":"Mild to Moderate Symptoms Do Not Correlate with Lactate Levels in HIV-Positive Patients on Nucleoside Reverse Transcriptase Inhibitors","year":2006,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Ontario HIV Treatment Network","keywords":"Medicine; Reverse transcriptase; Nucleoside Reverse Transcriptase Inhibitor; Human immunodeficiency virus (HIV); Nucleoside; Reverse-transcriptase inhibitor; Pharmacology; Internal medicine; Virology; Antiretroviral therapy; Viral load; RNA; Biochemistry","authors":[{"name":"Darrell H. S. Tan","is_ca":true},{"name":"Sharon Walmsley","is_ca":true},{"name":"Sandy Shen","is_ca":true},{"name":"Janet Raboud","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1136922117058813,"gpt":0.4102275988494202,"spread":0.2965353871435389,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006476818,0.0002906116,0.0003880977,0.0005352298,0.0003751677,0.0007167666,0.0002337515,0.0005105046,0.001896947],"category_scores_gemma":[0.005591197,0.0002848205,0.0003106209,0.0005632929,0.0003403799,0.0004715289,0.000383434,0.0005732958,0.0002605933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001720199,"about_ca_system_score_gemma":0.0002525188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001097401,"about_ca_topic_score_gemma":0.001340819,"domain_scores_codex":[0.9994247,0.0001848017,0.0001087552,0.00008386209,0.0001127958,0.00008502787],"domain_scores_gemma":[0.996151,0.0009987957,0.001728949,0.0001188924,0.000334585,0.0006677267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00009531047,0.00002425673,0.9990664,0.000007937371,0.0000171098,0.00006084032,0.00003540344,0.00001586556,0.0001341523,0.000003733966,0.00003189278,0.0005071405],"study_design_scores_gemma":[0.00001648703,0.0003305327,0.9983353,0.00001267513,0.00002954227,0.0006420695,0.0002098785,0.0002130751,0.00006695739,0.00002148248,0.0001175189,0.000004607928],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.999343,0.0002290378,0.00003755492,0.00004495079,0.000009040453,0.000006890035,0.00006814107,0.000001875346,0.0002596435],"genre_scores_gemma":[0.9997738,0.00004894821,0.00003207075,0.00002482304,0.000009323106,0.000002862011,0.00007166924,6.850391e-7,0.00003588074],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001896947,"threshold_uncertainty_score":0.006345928,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1981322336","doi":"10.1310/b45n-4xhb-53lu-jax9","title":"Selected Topics from the 38th Annual Meeting of the Infectious Diseases Society of America, September 7-10, 2000, New Orleans, Louisiana and Selected Topics from the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 17-20, 2000, Toronto, Ontario, Canada","year":2001,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Gerontology; Antimicrobial; Library science; Microbiology","authors":[{"name":"Gregory M. Lucus","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03259492114428208,"gpt":0.3132397287706411,"spread":0.280644807626359,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007992857,0.00264125,0.001774637,0.001701562,0.0008650165,0.002806275,0.000765286,0.002153632,0.31008],"category_scores_gemma":[0.001434483,0.0004293681,0.0007678439,0.00136761,0.0006013981,0.001184784,0.001080125,0.002235621,0.2172984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001348107,"about_ca_system_score_gemma":0.001405638,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004709546,"about_ca_topic_score_gemma":0.01937807,"domain_scores_codex":[0.9995006,0.00006183926,0.0000374659,0.00006753046,0.0002360878,0.000096523],"domain_scores_gemma":[0.9983834,0.0001429608,0.0001354466,0.00002431475,0.0007174428,0.0005964659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001606758,0.00007757765,0.0006243847,0.0004691761,0.00002034784,0.00009659208,0.00002552605,0.00007437907,0.0007907176,0.0002149701,0.9289384,0.06850722],"study_design_scores_gemma":[0.00006861281,0.0001533527,0.005187793,0.0005655045,0.0000302754,0.0001324857,0.00007422303,0.00006805485,0.0002389252,0.0002202495,0.9932377,0.00002277092],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.005008039,0.1298161,0.003212547,0.03156911,0.06805027,0.001394619,0.007694467,0.0009237429,0.7523311],"genre_scores_gemma":[0.004129583,0.06605519,0.001099827,0.004379045,0.01567835,0.000333269,0.002993867,0.0001332512,0.9051977],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.9952905,"threshold_uncertainty_score":0.9840872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111884657","doi":"10.1310/hct1306-335","title":"Abacavir/Lamivudine Fixed-Dose Combination With Ritonavir-Boosted Darunavir: A Safe and Efficacious Regimen for HIV Therapy","year":2012,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Abacavir; Darunavir; Emtricitabine; Lamivudine; Regimen; Ritonavir; Internal medicine; Gastroenterology; Viral load; Creatinine; Human immunodeficiency virus (HIV); Antiretroviral therapy; Immunology; Hepatitis B virus; Virus","authors":[{"name":"Benoît Trottier","is_ca":false},{"name":"Nimâ Machouf","is_ca":false},{"name":"Réjean Thomas","is_ca":false},{"name":"Serge Gallant","is_ca":false},{"name":"Danièle Longpré","is_ca":false},{"name":"Sylvie Vézina","is_ca":false},{"name":"Michel Boissonnault","is_ca":false},{"name":"Stéphane Lavoie","is_ca":false},{"name":"Danielle Legault","is_ca":false},{"name":"Harold Dion","is_ca":false},{"name":"Vinh Kim Nguyen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1741915860826942,"gpt":0.4424751159049179,"spread":0.2682835298222236,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002728751,0.0002691474,0.0003208974,0.0002549021,0.0002375789,0.0002707217,0.000311904,0.0002078264,0.002545437],"category_scores_gemma":[0.0002131335,0.00008195105,0.0001931734,0.0001571475,0.0001365033,0.00009823589,0.0001260234,0.0004828483,0.0007754176],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004401988,"about_ca_system_score_gemma":0.0006097154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002221101,"about_ca_topic_score_gemma":0.006179678,"domain_scores_codex":[0.9998323,0.00004854059,0.00001118817,0.00001687547,0.00006210325,0.00002898555],"domain_scores_gemma":[0.9999341,0.00000547276,0.00002066743,0.000005676433,0.00001048541,0.00002366602],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.004623309,0.002590743,0.02842944,0.0004931383,0.0001984954,0.002336168,0.0001985859,0.0005375996,0.07411403,0.0006252575,0.01135768,0.8744956],"study_design_scores_gemma":[0.02854712,0.06283733,0.556927,0.0007777882,0.0009048618,0.02614827,0.0002362436,0.006872396,0.04144503,0.001242785,0.2739515,0.0001097117],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9114989,0.05704965,0.006949391,0.002940088,0.0004405503,0.001548785,0.0007936529,0.0004621081,0.01831684],"genre_scores_gemma":[0.9755652,0.008741773,0.007955506,0.000847725,0.00042971,0.000251456,0.0005463093,0.00002469728,0.005637537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002545437,"threshold_uncertainty_score":0.008515358,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2037740736","doi":"10.1310/hct1304-179","title":"A Pilot, Prospective, Open-Label Simplification Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Once-Daily Lopinavir-Ritonavir Monotherapy in HIV-HCV Coinfected Patients: The MONOCO Study","year":2012,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; University of British Columbia; Ottawa Hospital; Abbott (Canada); University of Ottawa","funders":"Ontario HIV Treatment Network; Abbott Laboratories","keywords":"Medicine; Ritonavir; Lopinavir; Adverse effect; Pharmacokinetics; Prospective cohort study; Lopinavir/ritonavir; Internal medicine; Viral load; Pharmacology; Gastroenterology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Immunology","authors":[{"name":"Curtis Cooper","is_ca":true},{"name":"Charles la Porte","is_ca":true},{"name":"Harout Tossonian","is_ca":true},{"name":"John S. Sampalis","is_ca":true},{"name":"N Ackad","is_ca":true},{"name":"Brian Conway","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2869704247703874,"gpt":0.5185631127525557,"spread":0.2315926879821684,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004062824,0.001572813,0.002110868,0.0004515542,0.0008003612,0.0007367324,0.0007730647,0.000985457,0.00330652],"category_scores_gemma":[0.003130522,0.0007301185,0.001246649,0.0003482699,0.001276351,0.0008840477,0.0007681487,0.001575665,0.0006520306],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00076144,"about_ca_system_score_gemma":0.001359567,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001046522,"about_ca_topic_score_gemma":0.001461647,"domain_scores_codex":[0.99806,0.001197491,0.0001026667,0.0002152972,0.0002051105,0.0002193192],"domain_scores_gemma":[0.9960017,0.0007626255,0.00113989,0.0005630699,0.0003101463,0.001222702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8025727,0.1190608,0.02854282,0.0004124735,0.0009174214,0.0002491358,0.0006431154,0.0007006129,0.01539719,0.0001242321,0.0009228836,0.03045668],"study_design_scores_gemma":[0.2348762,0.7257382,0.03625377,0.00001351588,0.0003217952,0.0001329408,0.00007912628,0.0005916052,0.00105281,0.00007999191,0.0008267727,0.0000331607],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962603,0.0001906446,0.0003310299,0.00007174807,0.00002649658,0.002511241,0.000207564,0.00001874787,0.0003822721],"genre_scores_gemma":[0.992274,0.0002314347,0.001725713,0.0003416129,0.0001735448,0.00369188,0.0007154093,0.00001103373,0.0008353182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004062824,"threshold_uncertainty_score":0.02148658,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1996104688","doi":"10.1310/hct0805-259","title":"Randomized Controlled Trial of Once-Daily Tenofovir, Lamivudine, and Lopinavir/Ritonavir Versus Remaining on the Same Regimen in Virologically Suppressed HIV-Infected Patients on Their First PI-Containing HAART Regimen","year":2007,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; McGill University; Centre Hospitalier de l’Université de Montréal; Centre hospitalier de l'Université Laval; GDI Integrated Facility Services (Canada); St. Michael's Hospital; Western University; McMaster University Medical Centre; University of British Columbia; Abbott (Canada); University of Toronto","funders":"Abbott Canada; Gilead Sciences","keywords":"Medicine; Regimen; Lopinavir; Lamivudine; Ritonavir; Adverse effect; Discontinuation; Randomized controlled trial; Internal medicine; Lopinavir/ritonavir; Clinical endpoint; Viral load; Gastroenterology; Human immunodeficiency virus (HIV); Immunology; Virus; Antiretroviral therapy; Hepatitis B virus","authors":[{"name":"Mona Loutfy","is_ca":true},{"name":"N Ackad","is_ca":true},{"name":"Tony Antoniou","is_ca":true},{"name":"Jean-Guy Baril","is_ca":false},{"name":"Brian Conway","is_ca":true},{"name":"Joss de Wet","is_ca":true},{"name":"Benoît Trottier","is_ca":false},{"name":"Colin Kovacs","is_ca":true},{"name":"William A. Thompson","is_ca":true},{"name":"Alain Martel","is_ca":true},{"name":"Sylvie Trottier","is_ca":true},{"name":"Danielle Rouleau","is_ca":true},{"name":"Stephen D. Shafran","is_ca":true},{"name":"Anita Rachlis","is_ca":true},{"name":"Christophe Fraser","is_ca":false},{"name":"Fiona Smaill","is_ca":true},{"name":"Sharon Walmsley","is_ca":true},{"name":"Alice Tseng","is_ca":true},{"name":"John S. Sampalis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1190843410683194,"gpt":0.38938264742991,"spread":0.2702983063615906,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002694181,0.002178049,0.004938562,0.0005942958,0.000745583,0.001920306,0.001493465,0.003145514,0.008339358],"category_scores_gemma":[0.003835931,0.001134004,0.002448608,0.0005472127,0.001994183,0.00133849,0.000519264,0.004568941,0.001163456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008518472,"about_ca_system_score_gemma":0.001805467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001563908,"about_ca_topic_score_gemma":0.003124658,"domain_scores_codex":[0.9982083,0.001135107,0.0001152237,0.0002703353,0.0001125145,0.0001584764],"domain_scores_gemma":[0.9969802,0.00117083,0.0005966559,0.0002553586,0.000198821,0.0007980744],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9919355,0.004170618,0.000172895,0.0002322934,0.0004072585,0.00001373483,0.00001953251,0.00008357802,0.0004617124,0.00003580495,0.0001585645,0.002308481],"study_design_scores_gemma":[0.9760489,0.02301701,0.0003245079,0.00001252483,0.0001760994,0.000007552739,0.000008023655,0.0001966726,0.00007033904,0.00003733434,0.00009586565,0.000005052533],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9829332,0.003551758,0.0008668779,0.001047244,0.001943174,0.006755697,0.0009609131,0.0001668359,0.001774297],"genre_scores_gemma":[0.9812891,0.002134462,0.002594012,0.001856992,0.001217915,0.006647749,0.0008234422,0.00002850413,0.003407877],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008339358,"threshold_uncertainty_score":0.02789789,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}